<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29695883</article-id><article-id pub-id-type="pmc">5872012</article-id><article-id pub-id-type="publisher-id">BLT.17.203448</article-id><article-id pub-id-type="doi">10.2471/BLT.17.203448</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Reviews</subject></subj-group></article-categories><title-group><article-title>Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Revue syst&#x000e9;matique des interventions visant &#x000e0; promouvoir une utilisation rationnelle des antibiotiques en milieu hospitalier, dans les pays &#x000e0; revenu faible et interm&#x000e9;diaire</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Intervenciones de administraci&#x000f3;n de antibi&#x000f3;ticos en hospitales de pa&#x000ed;ses con ingresos bajos y medios: una revisi&#x000f3;n sistem&#x000e1;tica</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00634;&#x00631;&#x00627;&#x00641; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00648;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;: &#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00629;&#x000a0;&#x00645;&#x00646;&#x00647;&#x0062c;&#x0064a;&#x00629; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x04f4e;&#x06536;&#x05165;&#x0548c;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x0533b;&#x09662;&#x05bf9;&#x06297;&#x0751f;&#x07d20;&#x07684;&#x07ba1;&#x07406;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff1a;&#x07cfb;&#x07edf;&#x08bc4;&#x04ef7;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00412;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00435;&#x00433;&#x00438;&#x00438; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00430;&#x0043a;&#x00442;&#x00435;&#x00440;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00432; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00446;&#x00430;&#x00445; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f;: &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Christophe Van Dijck et al.</alt-title><alt-title alt-title-type="title-running-head">Antibiotic stewardship in low- and middle-income countries</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Van Dijck</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vlieghe</surname><given-names>Erika</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>Janneke Arnoldine</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><aff id="aff1"><label>a</label>Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijkstraat 10, B-2650 Edegem, <country>Belgium</country>.</aff><aff id="aff2"><label>b</label>Unit of Internal Medicine and Infectious Diseases, <institution>University Hospital Antwerp</institution>, <addr-line>Antwerp</addr-line>, <country>Belgium</country>.</aff><aff id="aff3"><label>c</label>Unit of Tropical Laboratory Medicine, <institution>Institute of Tropical Medicine</institution>, <addr-line>Antwerp</addr-line>, <country>Belgium</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Christophe Van Dijck (email: <email xlink:href="christophe.vandijck@gmail.com">christophe.vandijck@gmail.com</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>2</month><year>2018</year></pub-date><volume>96</volume><issue>4</issue><fpage>266</fpage><lpage>280</lpage><history><date date-type="received"><day>04</day><month>10</month><year>2017</year></date><date date-type="rev-recd"><day>26</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>(c) 2018 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To review the effectiveness of antibiotic stewardship interventions in hospitals in low- and middle-income countries.</p></sec><sec><title>Methods</title><p>We searched MEDLINE&#x000ae;, Embase&#x000ae;, Cochrane Central Register of Controlled Trials and regional indexes for studies of interventions to improve appropriate prescribing and use of antibiotics for hospitalized patients in low- and middle-income countries. We included controlled trials, controlled before-and-after studies and interrupted time-series studies published up to December 2017. We report prescribing, clinical and microbiological outcomes using a narrative approach.</p></sec><sec><title>Findings</title><p>We screened 7342 original titles and abstracts, assessed 241 full-text articles and included 27 studies from 2 low-income and 11 middle-income countries. We found a medium (11 studies) or high risk (13 studies) of bias. Generally, all types of interventions (structural, persuasive and enabling) and intervention bundles were reported to improve prescribing and clinical outcomes. However, the studied interventions and reported outcomes varied widely. The most frequent intervention was procalcitonin-guided antibiotic treatment (8 of 27 studies, all randomized controlled trials). The intervention was associated with a relative risk for patients receiving antibiotics ranging between 0.40 and 0.87.</p></sec><sec><title>Conclusion</title><p>The majority of studies reported a positive effect of hospital antibiotic stewardship interventions. However, we cannot draw general conclusions about the effectiveness of such interventions in low- and middle-income countries because of low study quality, heterogeneity of interventions and outcomes, and under-representation of certain settings. To strengthen the evidence base, action needs to be taken to address these shortcomings.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>&#x000c9;tudier l'efficacit&#x000e9; des interventions visant un usage plus rationnel des antibiotiques dans les h&#x000f4;pitaux de pays &#x000e0; revenu faible et interm&#x000e9;diaire.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons consult&#x000e9; MEDLINE&#x000ae;, Embase&#x000ae;, le registre central Cochrane des essais contr&#x000f4;l&#x000e9;s ainsi que des index r&#x000e9;gionaux afin de rechercher des &#x000e9;tudes portant sur des interventions men&#x000e9;es pour am&#x000e9;liorer la prescription et l'usage des antibiotiques pour les patients hospitalis&#x000e9;s, dans des pays &#x000e0; revenu faible et interm&#x000e9;diaire. Nous avons inclus des essais contr&#x000f4;l&#x000e9;s, des &#x000e9;tudes contr&#x000f4;l&#x000e9;es avant/apr&#x000e8;s et des &#x000e9;tudes en s&#x000e9;ries temporelles interrompues, publi&#x000e9;s jusqu'&#x000e0; d&#x000e9;cembre&#x000a0;2017. Nous &#x000e9;voquons ici, en adoptant une approche narrative, les r&#x000e9;sultats obtenus en termes de prescription et aux niveaux clinique et microbiologique.</p></sec><sec><title>R&#x000e9;sultats</title><p>Nous avons s&#x000e9;lectionn&#x000e9; 7342&#x000a0;r&#x000e9;sum&#x000e9;s et titres originaux, &#x000e9;valu&#x000e9; 241&#x000a0;articles dans leur version int&#x000e9;grale et inclus 27&#x000a0;&#x000e9;tudes, pour 2&#x000a0;pays &#x000e0; faible revenu et 11&#x000a0;pays &#x000e0; revenu interm&#x000e9;diaire. Nous avons identifi&#x000e9; un risque de biais moyen (11&#x000a0;&#x000e9;tudes) ou &#x000e9;lev&#x000e9; (13&#x000a0;&#x000e9;tudes). En r&#x000e8;gle g&#x000e9;n&#x000e9;rale, ces publications indiquent que tous les types d'interventions (structurelles, persuasives et capacitantes) ainsi que toutes les interventions combin&#x000e9;es ont permis d'am&#x000e9;liorer les r&#x000e9;sultats en termes de prescription et au niveau clinique. Cependant, les interventions &#x000e9;tudi&#x000e9;es et les r&#x000e9;sultats publi&#x000e9;s sont extr&#x000ea;mement vari&#x000e9;s. L'intervention la plus fr&#x000e9;quente a consist&#x000e9; &#x000e0; guider les antibioth&#x000e9;rapies en utilisant la procalcitonine (8&#x000a0;&#x000e9;tudes sur 27; toutes correspondent &#x000e0; des essais contr&#x000f4;l&#x000e9;s randomis&#x000e9;s). Pour les patients, cette intervention a &#x000e9;t&#x000e9; associ&#x000e9;e &#x000e0; un risque relatif de prescription d&#x02019;antibiotiques compris entre 0,40 et 0,87.</p></sec><sec><title>Conclusion</title><p>La majorit&#x000e9; des &#x000e9;tudes font &#x000e9;tat d'un effet positif des interventions visant &#x000e0; promouvoir l'usage rationnel des antibiotiques en milieu hospitalier. N&#x000e9;anmoins, nous ne pouvons pas tirer de conclusions g&#x000e9;n&#x000e9;rales sur l'efficacit&#x000e9; de ces interventions dans les pays &#x000e0; revenu faible ou interm&#x000e9;diaire, compte tenu de la mauvaise qualit&#x000e9; des &#x000e9;tudes, de l'h&#x000e9;t&#x000e9;rog&#x000e9;n&#x000e9;it&#x000e9; des interventions et des r&#x000e9;sultats ainsi que de la sous-repr&#x000e9;sentation de certains contextes. Pour consolider les donn&#x000e9;es disponibles, des actions doivent &#x000ea;tre entreprises afin de combler ces lacunes.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Revisar la eficacia de las intervenciones de administraci&#x000f3;n de antibi&#x000f3;ticos en hospitales de pa&#x000ed;ses con ingresos medios y bajos.</p></sec><sec><title>M&#x000e9;todos</title><p>Se realizaron b&#x000fa;squedas en MEDLINE&#x000ae;, Embase&#x000ae;, en el Registro Central de Ensayos Controlados Cochrane y en &#x000ed;ndices regionales en relaci&#x000f3;n a estudios de intervenciones para mejorar la prescripci&#x000f3;n y el uso adecuado de antibi&#x000f3;ticos para pacientes hospitalizados en pa&#x000ed;ses con ingresos medios y bajos. Incluimos ensayos controlados, estudios controlados de tipo antes y despu&#x000e9;s y estudios de series de tiempo interrumpido publicados hasta diciembre de 2017. Informamos acerca de los resultados de prescripci&#x000f3;n, cl&#x000ed;nicos y microbiol&#x000f3;gicos usando un enfoque narrativo.</p></sec><sec><title>Resultados</title><p>Revisamos 7342 t&#x000ed;tulos originales y res&#x000fa;menes, evaluamos 241 art&#x000ed;culos de texto completos, incluidos 27 estudios de 2 pa&#x000ed;ses con ingresos bajos y 11 con ingresos medios. Encontramos riesgo medio de sesgo (11 estudios) o riesgo alto (13 estudios). Por lo general, se inform&#x000f3; de que todos los tipos de intervenciones (estructurales, persuasivas y permisivas) y conjuntos de intervenciones mejoran los resultados de prescripci&#x000f3;n y los resultados cl&#x000ed;nicos. Sin embargo, las intervenciones estudiadas y los resultados sobre los que se inform&#x000f3; var&#x000ed;an considerablemente. La intervenci&#x000f3;n m&#x000e1;s frecuente fue el tratamiento antibi&#x000f3;tico guiado de procalcitonina (8 de 27 estudios, todos ellos ensayos controlados aleatorizados). La intervenci&#x000f3;n se asoci&#x000f3; a un riesgo relativo para pacientes que recib&#x000ed;an antibi&#x000f3;ticos que oscilan entre 0,40 y 0,87.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>La mayor&#x000ed;a de los estudios informaron sobre un efecto positivo de las intervenciones hospitalarias con administraci&#x000f3;n de antibi&#x000f3;ticos. Sin embargo, no podemos extraer conclusiones generales acerca de la efectividad de tales intervenciones en pa&#x000ed;ses con ingresos medios y bajos debido a la baja calidad del estudio, a la heterogeneidad de las intervenciones y los resultados y a la baja representaci&#x000f3;n de ciertas regiones. Para fortalecer la base de las evidencias, es necesario tomar medidas para abordar estas deficiencias.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00627;&#x00644;&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00629; &#x00641;&#x00627;&#x00639;&#x00644;&#x0064a;&#x00629; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00634;&#x00631;&#x00627;&#x00641; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00648;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x00625;&#x0062c;&#x00631;&#x00627;&#x00621; &#x00628;&#x0062d;&#x0062b; &#x00641;&#x0064a; MEDLINE&#x000ae;&#x0200e;&#x0060c; &#x00648;Embase&#x000ae;&#x0200e;&#x0060c; &#x00648;&#x00633;&#x0062c;&#x00644; Cochrane &#x00627;&#x00644;&#x00645;&#x00631;&#x00643;&#x00632;&#x0064a; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635; &#x00628;&#x00627;&#x00644;&#x0062a;&#x0062c;&#x00627;&#x00631;&#x00628; &#x00627;&#x00644;&#x00645;&#x00636;&#x00628;&#x00637;&#x00629; &#x00628;&#x00627;&#x00644;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f; &#x00648;&#x00627;&#x00644;&#x00645;&#x00624;&#x00634;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00642;&#x00644;&#x0064a;&#x00645;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00628;&#x00647;&#x0062f;&#x00641; &#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00648;&#x00635;&#x00641; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00648;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00633;&#x00628;&#x00629; &#x00648;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0062a;&#x00645; &#x00625;&#x0062f;&#x0062e;&#x00627;&#x00644;&#x00647;&#x00645; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00648;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;. &#x00648;&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00636;&#x00645;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00627;&#x00631;&#x00628; &#x00627;&#x00644;&#x00645;&#x00636;&#x00628;&#x00637;&#x00629; &#x00628;&#x00627;&#x00644;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f;&#x0060c; &#x00648;&#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00628;&#x00644;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00628;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00636;&#x00628;&#x00637;&#x00629; &#x00628;&#x00627;&#x00644;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f; &#x00648;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x00644;&#x00627;&#x00633;&#x00644; &#x00627;&#x00644;&#x00632;&#x00645;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00642;&#x00637;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645; &#x00646;&#x00634;&#x00631;&#x00647;&#x00627; &#x0062d;&#x0062a;&#x00649; &#x00634;&#x00647;&#x00631; &#x0062f;&#x0064a;&#x00633;&#x00645;&#x00628;&#x00631;/&#x00643;&#x00627;&#x00646;&#x00648;&#x00646; &#x00627;&#x00644;&#x00623;&#x00648;&#x00644; 2017. &#x00648;&#x00644;&#x00642;&#x0062f; &#x00623;&#x00648;&#x00631;&#x0062f; &#x0062a;&#x00642;&#x00631;&#x0064a;&#x00631;&#x00646;&#x00627; &#x00639;&#x00644;&#x00649; &#x00645;&#x0062d;&#x00635;&#x00644;&#x00627;&#x0062a; &#x00645;&#x00643;&#x00631;&#x00648;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00648;&#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00648;&#x00648;&#x00635;&#x00641;&#x0064a;&#x00629; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x00646;&#x00647;&#x0062c; &#x00627;&#x00644;&#x00633;&#x00631;&#x0062f;&#x0064a;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x00643;&#x00645;&#x00627; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x00641;&#x0062d;&#x00635; 7342 &#x00645;&#x00646; &#x00627;&#x00644;&#x00639;&#x00646;&#x00627;&#x00648;&#x0064a;&#x00646; &#x00648;&#x00627;&#x00644;&#x00645;&#x00644;&#x0062e;&#x00635;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00635;&#x00644;&#x0064a;&#x00629;&#x0060c; &#x00648;&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; 241 &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00642;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00635; &#x00627;&#x00644;&#x00643;&#x00627;&#x00645;&#x00644;&#x0060c; &#x00648;&#x0062a;&#x00645; &#x0062a;&#x00636;&#x00645;&#x0064a;&#x00646; 27 &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00645;&#x00646; &#x00627;&#x0062b;&#x00646;&#x0062a;&#x0064a;&#x00646; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; &#x00648;11&#x000a0;&#x00628;&#x00644;&#x0062f;&#x0064b;&#x00627; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;. &#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; (11&#x000a0;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;) &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x00645;&#x00646; &#x00627;&#x0062e;&#x0062a;&#x00637;&#x00627;&#x00631; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x0064a;&#x00632;&#x0060c; &#x00623;&#x00648; (13&#x000a0;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;) &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00645;&#x00631;&#x0062a;&#x00641;&#x00639; &#x00645;&#x00646; &#x00627;&#x0062e;&#x0062a;&#x00637;&#x00627;&#x00631; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x0064a;&#x00632;. &#x00628;&#x00634;&#x00643;&#x00644; &#x00639;&#x00627;&#x00645;&#x0060c; &#x0062a;&#x00645; &#x00627;&#x00644;&#x00625;&#x00628;&#x00644;&#x00627;&#x0063a; &#x00639;&#x00646; &#x00643;&#x00644; &#x00623;&#x00634;&#x00643;&#x00627;&#x00644; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; (&#x00627;&#x00644;&#x00647;&#x0064a;&#x00643;&#x00644;&#x0064a;&#x00629;&#x0060c; &#x00648;&#x00627;&#x00644;&#x00645;&#x00642;&#x00646;&#x00639;&#x00629;&#x0060c; &#x00648;&#x00627;&#x00644;&#x0062a;&#x00645;&#x00643;&#x0064a;&#x00646;&#x0064a;&#x00629;) &#x00648;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00628;&#x00647;&#x0062f;&#x00641; &#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062d;&#x00635;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00648;&#x00635;&#x00641;&#x0064a;&#x00629;. &#x00648;&#x00645;&#x00639; &#x00630;&#x00644;&#x00643;&#x0060c; &#x00641;&#x00642;&#x0062f; &#x0062a;&#x00628;&#x00627;&#x0064a;&#x00646;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062d;&#x00635;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00628;&#x00644;&#x0063a; &#x00639;&#x00646;&#x00647;&#x00627; &#x00628;&#x00634;&#x00643;&#x00644; &#x00643;&#x00628;&#x0064a;&#x00631;. &#x00648;&#x00643;&#x00627;&#x00646; &#x00623;&#x00643;&#x0062b;&#x00631; &#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00645;&#x0062a;&#x00643;&#x00631;&#x00631; &#x00647;&#x00648; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00648;&#x0062c;&#x00647; &#x00628;&#x00631;&#x00648;&#x00643;&#x00644;&#x00633;&#x0064a;&#x0062a;&#x00648;&#x00646;&#x0064a;&#x00646; (8 &#x00645;&#x00646; 27&#x000a0;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;&#x0060c; &#x00643;&#x00644; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00627;&#x00631;&#x00628; &#x00627;&#x00644;&#x00645;&#x00639;&#x00634;&#x00627;&#x00629; &#x00627;&#x00644;&#x00645;&#x00636;&#x00628;&#x00637;&#x00629; &#x00628;&#x00634;&#x00648;&#x00627;&#x00647;&#x0062f;). &#x00648;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00637; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00628;&#x0062e;&#x00637;&#x00631; &#x00646;&#x00633;&#x00628;&#x0064a; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0064a;&#x0062a;&#x00646;&#x00627;&#x00648;&#x00644;&#x00648;&#x00646; &#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x0062a;&#x0062a;&#x00631;&#x00627;&#x00648;&#x0062d; &#x00646;&#x00633;&#x00628;&#x0062a;&#x00647; &#x00645;&#x00627; &#x00628;&#x0064a;&#x00646; 0.40 &#x00648;0.87. </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x00623;&#x00628;&#x00644;&#x0063a;&#x0062a; &#x00645;&#x00639;&#x00638;&#x00645; &#x00627;&#x00644;&#x0062f;&#x00627;&#x00631;&#x00633;&#x00627;&#x0062a; &#x00639;&#x00646; &#x00648;&#x0062c;&#x00648;&#x0062f; &#x00623;&#x0062b;&#x00631; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a; &#x00641;&#x0064a;&#x00645;&#x00627; &#x0064a;&#x0062e;&#x00635; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00634;&#x00631;&#x00627;&#x00641; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00648;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x0064a;&#x00627;&#x0062a;. &#x00648;&#x00645;&#x00639; &#x00630;&#x00644;&#x00643;&#x0060c; &#x00644;&#x00627; &#x0064a;&#x00645;&#x00643;&#x00646;&#x00646;&#x00627; &#x00627;&#x00644;&#x00648;&#x00635;&#x00648;&#x00644; &#x00625;&#x00644;&#x00649; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00646;&#x00647;&#x00627;&#x00626;&#x0064a;&#x00629; &#x0062a;&#x0062e;&#x00635; &#x00641;&#x00627;&#x00639;&#x00644;&#x0064a;&#x00629; &#x0062a;&#x00644;&#x00643; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; &#x00648;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;&#x0060c; &#x00628;&#x00633;&#x00628;&#x00628; &#x00627;&#x00644;&#x0062c;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00646;&#x00648;&#x00639;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x0062f;&#x00646;&#x0064a;&#x00629; &#x00644;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a;&#x0060c; &#x00648;&#x00639;&#x00646;&#x00635;&#x00631; &#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x0062a;&#x0062c;&#x00627;&#x00646;&#x00633; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062d;&#x00635;&#x00644;&#x00627;&#x0062a;&#x0060c; &#x00648;&#x00627;&#x00644;&#x0062a;&#x00645;&#x0062b;&#x0064a;&#x00644; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00643;&#x00627;&#x00641;&#x0064a; &#x00644;&#x00645;&#x00646;&#x00627;&#x00637;&#x00642; &#x00645;&#x00639;&#x0064a;&#x00646;&#x00629;. &#x00648;&#x0062d;&#x00631;&#x00635;&#x0064b;&#x00627; &#x00639;&#x00644;&#x00649; &#x0062a;&#x00639;&#x00632;&#x0064a;&#x00632; &#x00642;&#x00627;&#x00639;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00644;&#x00629;&#x0060c; &#x00641;&#x00625;&#x00646;&#x00646;&#x00627; &#x00646;&#x0062d;&#x0062a;&#x00627;&#x0062c; &#x00625;&#x00644;&#x00649; &#x00627;&#x0062a;&#x0062d;&#x00627;&#x00630; &#x00627;&#x00644;&#x00625;&#x0062c;&#x00631;&#x00627;&#x00621;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00644;&#x00627;&#x00632;&#x00645;&#x00629; &#x00644;&#x0062a;&#x00639;&#x00648;&#x0064a;&#x00636; &#x00647;&#x00630;&#x00627; &#x00627;&#x00644;&#x00642;&#x00635;&#x00648;&#x00631;. <bold/></p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;&#x0ff1a;</title><p>&#x08bc4;&#x04ef7;&#x04f4e;&#x06536;&#x05165;&#x0548c;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x0533b;&#x09662;&#x05bf9;&#x06297;&#x0751f;&#x07d20;&#x07684;&#x07ba1;&#x07406;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x07684;&#x06709;&#x06548;&#x06027;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;&#x0ff1a;</title><p>&#x06211;&#x04eec;&#x05206;&#x0522b;&#x05728;&#x000a0;MEDLINE&#x000ae;&#x03001;Embase&#x000ae;&#x03001;Cochrane&#x000a0;&#x04e34;&#x05e8a;&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;&#x04e2d;&#x05fc3;&#x06ce8;&#x0518c;&#x06570;&#x0636e;&#x05e93;&#x04e2d;&#x08fdb;&#x0884c;&#x068c0;&#x07d22;&#x0ff0c;&#x07528;&#x04e8e;&#x07814;&#x07a76;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff0c;&#x04ee5;&#x06539;&#x05584;&#x04f4e;&#x06536;&#x05165;&#x0548c;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x04f4f;&#x09662;&#x060a3;&#x08005;&#x09002;&#x05f53;&#x07684;&#x05f00;&#x05177;&#x05904;&#x065b9;&#x0548c;&#x04f7f;&#x07528;&#x06297;&#x0751f;&#x07d20;&#x03002;&#x06211;&#x04eec;&#x05305;&#x062ec;&#x04e86;&#x053d1;&#x08868;&#x081f3;&#x000a0;2017&#x000a0;&#x05e74;&#x000a0;12&#x000a0;&#x06708;&#x07684;&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;&#x03001;&#x0524d;&#x0540e;&#x05bf9;&#x07167;&#x07814;&#x07a76;&#x0548c;&#x065ad;&#x07eed;&#x065f6;&#x095f4;&#x05e8f;&#x05217;&#x07814;&#x07a76;&#x03002;&#x06211;&#x04eec;&#x04f7f;&#x07528;&#x053d9;&#x08ff0;&#x06027;&#x065b9;&#x06cd5;&#x06765;&#x062a5;&#x0544a;&#x05904;&#x065b9;&#x03001;&#x04e34;&#x05e8a;&#x0548c;&#x05fae;&#x0751f;&#x07269;&#x07ed3;&#x0679c;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x0ff1a;&#x06211;&#x04eec;&#x07b5b;&#x09009;&#x04e86;&#x000a0;7342&#x000a0;&#x06761;&#x0539f;&#x06807;&#x09898;&#x0548c;&#x06458;&#x08981;&#x0ff0c;&#x08bc4;&#x04f30;&#x04e86;&#x000a0;241&#x000a0;&#x07bc7;&#x05168;&#x06587;&#x06587;&#x0732e;&#x0ff0c;&#x05176;&#x04e2d;&#x05305;&#x062ec;&#x06765;&#x081ea;&#x000a0;2&#x000a0;&#x04e2a;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x0548c;&#x000a0;11&#x000a0;&#x04e2a;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x000a0;27&#x000a0;&#x09879;&#x07814;&#x07a76;&#x03002;&#x06211;&#x04eec;&#x053d1;&#x073b0;&#x04e86;&#x04e2d;&#x07b49;&#x0ff08;11&#x000a0;&#x09879;&#x07814;&#x07a76;&#x0ff09;&#x06216;&#x09ad8;&#x07b49;&#x0ff08;13&#x000a0;&#x09879;&#x07814;&#x07a76;&#x0ff09;&#x0504f;&#x0501a;&#x098ce;&#x09669;&#x03002;&#x0666e;&#x0904d;&#x06765;&#x08bf4;&#x0ff0c;&#x06240;&#x06709;&#x07c7b;&#x0578b;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff08;&#x07ed3;&#x06784;&#x0578b;&#x03001;&#x0529d;&#x05bfc;&#x0578b;&#x0548c;&#x06388;&#x06743;&#x0578b;&#x0ff09;&#x0548c;&#x05e72;&#x09884;&#x07ec4;&#x05408;&#x063aa;&#x065bd;&#x0636e;&#x062a5;&#x0544a;&#x053ef;&#x06539;&#x05584;&#x05904;&#x065b9;&#x0548c;&#x04e34;&#x05e8a;&#x07ed3;&#x0679c;&#x03002;&#x07136;&#x0800c;&#x0ff0c;&#x07814;&#x07a76;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0548c;&#x062a5;&#x0544a;&#x07684;&#x07ed3;&#x0679c;&#x05dee;&#x05f02;&#x05f88;&#x05927;&#x03002;&#x06700;&#x05e38;&#x089c1;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0662f;&#x0964d;&#x09499;&#x07d20;&#x0539f;&#x06307;&#x05bfc;&#x07684;&#x06297;&#x0751f;&#x07d20;&#x06cbb;&#x07597;&#x0ff08;&#x06240;&#x06709;&#x000a0;27&#x000a0;&#x04f8b;&#x0968f;&#x0673a;&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;&#x07814;&#x07a76;&#x04e2d;&#x06709;&#x000a0;8&#x000a0;&#x04f8b;&#x091c7;&#x07528;&#x06b64;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff09;&#x03002;&#x06b64;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x05bf9;&#x063a5;&#x053d7;&#x06297;&#x0751f;&#x07d20;&#x06cbb;&#x07597;&#x060a3;&#x08005;&#x07684;&#x076f8;&#x05bf9;&#x05371;&#x09669;&#x08303;&#x056f4;&#x04e3a;&#x000a0;0.40&#x000a0;&#x081f3;&#x000a0;0.87&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;&#x0ff1a;</title><p>&#x05927;&#x0591a;&#x06570;&#x07814;&#x07a76;&#x062a5;&#x0544a;&#x04e86;&#x0533b;&#x09662;&#x06297;&#x0751f;&#x07d20;&#x07ba1;&#x07406;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x07684;&#x079ef;&#x06781;&#x06548;&#x0679c;&#x03002;&#x07136;&#x0800c;&#x0ff0c;&#x07531;&#x04e8e;&#x07814;&#x07a76;&#x08d28;&#x091cf;&#x08f83;&#x04f4e;&#x03001;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x053ca;&#x05176;&#x07ed3;&#x0679c;&#x07684;&#x05f02;&#x08d28;&#x06027;&#x04ee5;&#x053ca;&#x067d0;&#x04e9b;&#x080cc;&#x0666f;&#x07684;&#x04ee3;&#x08868;&#x06027;&#x04e0d;&#x08db3;&#x0ff0c;&#x06211;&#x04eec;&#x04e0d;&#x080fd;&#x05c31;&#x08fd9;&#x04e9b;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x05728;&#x04f4e;&#x06536;&#x05165;&#x0548c;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x06709;&#x06548;&#x06027;&#x05f97;&#x051fa;&#x04e00;&#x0822c;&#x06027;&#x07ed3;&#x08bba;&#x03002;&#x04e3a;&#x04e86;&#x052a0;&#x05f3a;&#x08bc1;&#x0636e;&#x057fa;&#x07840;&#x0ff0c;&#x09700;&#x08981;&#x091c7;&#x053d6;&#x0884c;&#x052a8;&#x06765;&#x089e3;&#x051b3;&#x08fd9;&#x04e9b;&#x04e0d;&#x08db3;&#x03002;<bold/></p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00441;&#x00442;&#x00438; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00435;&#x00433;&#x00438;&#x00438; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00430;&#x0043a;&#x00442;&#x00435;&#x00440;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00432; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00446;&#x00430;&#x00445; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043b;&#x00438; &#x0043f;&#x0043e;&#x00438;&#x00441;&#x0043a; &#x00432; &#x00431;&#x00430;&#x00437;&#x00430;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; MEDLINE&#x000ae;, Embase&#x000ae;, &#x00426;&#x00435;&#x0043d;&#x00442;&#x00440;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x0041a;&#x0043e;&#x0043a;&#x00440;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00440;&#x00435;&#x00435;&#x00441;&#x00442;&#x00440;&#x00435; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00445; &#x00438;&#x00441;&#x0043f;&#x0044b;&#x00442;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00438; &#x00440;&#x00435;&#x00433;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043c;&#x00435;&#x00442;&#x0043d;&#x0044b;&#x00445; &#x00443;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044f;&#x00445; &#x0043d;&#x00430; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043c;&#x00435;&#x00442; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432; &#x00441; &#x00446;&#x00435;&#x0043b;&#x0044c;&#x0044e; &#x0043e;&#x0043f;&#x00442;&#x00438;&#x0043c;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00438;&#x0043e;&#x00442;&#x00438;&#x0043a;&#x0043e;&#x00432; &#x00434;&#x0043b;&#x0044f; &#x00433;&#x0043e;&#x00441;&#x0043f;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f;. &#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00438;&#x0043b;&#x00438; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00435; &#x00438;&#x00441;&#x0043f;&#x0044b;&#x00442;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00434;&#x0043e; &#x00438; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430; &#x00438; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043f;&#x00440;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00440;&#x0044f;&#x00434;&#x0043e;&#x00432;, &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00434;&#x0043e; &#x00434;&#x00435;&#x0043a;&#x00430;&#x00431;&#x00440;&#x0044f; 2017&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;. &#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00441;&#x0043e;&#x0043e;&#x00431;&#x00449;&#x00430;&#x0044e;&#x00442; &#x0043e; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f;&#x00445;, &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00430;&#x00445; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438; &#x0043c;&#x00438;&#x0043a;&#x00440;&#x0043e;&#x00431;&#x00438;&#x0043e;&#x0043b;&#x0043e;&#x00433;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x00443;&#x0044f; &#x0043e;&#x0043f;&#x00438;&#x00441;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x0043f;&#x0043e;&#x00434;&#x00445;&#x0043e;&#x00434;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00441;&#x0043c;&#x0043e;&#x00442;&#x00440;&#x00435;&#x0043b;&#x00438; 7342&#x000a0;&#x0043e;&#x00440;&#x00438;&#x00433;&#x00438;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00437;&#x00434;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x00440;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;, &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x0043b;&#x00438; 241&#x000a0;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x0043e;&#x00442;&#x00435;&#x0043a;&#x00441;&#x00442;&#x0043e;&#x00432;&#x00443;&#x0044e; &#x00441;&#x00442;&#x00430;&#x00442;&#x0044c;&#x0044e; &#x00438; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00438;&#x0043b;&#x00438; 27&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00438;&#x00437; 2&#x000a0;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; 11&#x000a0;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d; &#x00441;&#x0043e; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c;. &#x00411;&#x0044b;&#x0043b; &#x0043e;&#x00431;&#x0043d;&#x00430;&#x00440;&#x00443;&#x00436;&#x00435;&#x0043d; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x00439;&#x000a0;(11&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;) &#x00438; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x00439; &#x00440;&#x00438;&#x00441;&#x0043a;&#x000a0;(13&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;) &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x0043e;&#x00448;&#x00438;&#x00431;&#x0043a;&#x00438;. &#x00412; &#x00446;&#x00435;&#x0043b;&#x0043e;&#x0043c; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x0043e;&#x00442;&#x0043c;&#x00435;&#x00447;&#x00435;&#x0043d;&#x0043e;, &#x00447;&#x00442;&#x0043e; &#x00432;&#x00441;&#x00435; &#x00432;&#x00438;&#x00434;&#x0044b; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x000a0;(&#x00441;&#x00442;&#x00440;&#x00443;&#x0043a;&#x00442;&#x00443;&#x00440;&#x0043d;&#x0044b;&#x00435; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430;, &#x00443;&#x00431;&#x00435;&#x00436;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00438; &#x00441;&#x0043e;&#x00437;&#x00434;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00431;&#x0043b;&#x00430;&#x00433;&#x0043e;&#x0043f;&#x00440;&#x00438;&#x0044f;&#x00442;&#x0043d;&#x0044b;&#x00445; &#x00443;&#x00441;&#x0043b;&#x0043e;&#x00432;&#x00438;&#x00439;), &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00438;&#x00445; &#x0043a;&#x0043e;&#x0043c;&#x0043f;&#x0043b;&#x00435;&#x0043a;&#x00441;&#x0044b; &#x0043e;&#x0043f;&#x00442;&#x00438;&#x0043c;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x0043d;&#x00430;&#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00430;&#x0043a;&#x00442;&#x00435;&#x00440;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00438; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;. &#x00422;&#x00435;&#x0043c; &#x0043d;&#x00435; &#x0043c;&#x00435;&#x0043d;&#x00435;&#x00435; &#x00438;&#x00437;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430; &#x00438; &#x00437;&#x00430;&#x00440;&#x00435;&#x00433;&#x00438;&#x00441;&#x00442;&#x00440;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b; &#x00441;&#x00438;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00440;&#x00430;&#x00437;&#x0043b;&#x00438;&#x00447;&#x00430;&#x0043b;&#x00438;&#x00441;&#x0044c;. &#x0041d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00447;&#x00430;&#x00441;&#x00442;&#x0044b;&#x0043c; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x0043e;&#x0043c; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00443;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00438;&#x0043e;&#x00442;&#x00438;&#x0043a;&#x0043e;&#x00442;&#x00435;&#x00440;&#x00430;&#x0043f;&#x00438;&#x00435;&#x00439; &#x0043d;&#x00430; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x00435; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x0044f; &#x0043f;&#x00440;&#x0043e;&#x0043a;&#x00430;&#x0043b;&#x0044c;&#x00446;&#x00438;&#x00442;&#x0043e;&#x0043d;&#x00438;&#x0043d;&#x00430; &#x00432; &#x0043a;&#x00440;&#x0043e;&#x00432;&#x00438;&#x000a0;(8 &#x00438;&#x00437; 27&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x00432;&#x00441;&#x00435;&#x000a0;&#x02014; &#x00440;&#x00430;&#x0043d;&#x00434;&#x0043e;&#x0043c;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;). &#x00412;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043e; &#x00441; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c; &#x00440;&#x00438;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00434;&#x0043b;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00432;&#x00448;&#x00438;&#x00445; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00438;&#x0043e;&#x00442;&#x00438;&#x0043a;&#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432;, &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c; &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0043e;&#x00433;&#x0043e; &#x0043d;&#x00430;&#x00445;&#x0043e;&#x00434;&#x00438;&#x0043b;&#x00441;&#x0044f; &#x00432; &#x00434;&#x00438;&#x00430;&#x0043f;&#x00430;&#x00437;&#x0043e;&#x0043d;&#x00435; &#x0043e;&#x00442; 0,40 &#x00434;&#x0043e; 0,87.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00412; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00438;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00441;&#x0043e;&#x0043e;&#x00431;&#x00449;&#x00430;&#x0043b;&#x0043e;&#x00441;&#x0044c; &#x0043e; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00435; &#x00432;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00435;&#x00433;&#x00438;&#x00438; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00431;&#x00430;&#x0043a;&#x00442;&#x00435;&#x00440;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x00435;&#x0043f;&#x00430;&#x00440;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00432; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x00438;&#x00446;&#x00430;&#x00445;. &#x0041e;&#x00434;&#x0043d;&#x00430;&#x0043a;&#x0043e; &#x00430;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043d;&#x00435; &#x0043c;&#x0043e;&#x00433;&#x00443;&#x00442; &#x00441;&#x00434;&#x00435;&#x0043b;&#x00430;&#x00442;&#x0044c; &#x0043e;&#x00431;&#x00449;&#x00438;&#x00445; &#x00432;&#x0044b;&#x00432;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043e;&#x00431; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00442;&#x00430;&#x0043a;&#x00438;&#x00445; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438;&#x00437;-&#x00437;&#x00430; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x0043a;&#x00430;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00430; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x0043d;&#x00435;&#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432; &#x00438; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00432; &#x00438; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00430;&#x00440;&#x00430;&#x0043c;&#x00435;&#x00442;&#x00440;&#x0043e;&#x00432;. &#x00414;&#x0043b;&#x0044f; &#x00443;&#x0043a;&#x00440;&#x00435;&#x0043f;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00434;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00431;&#x00430;&#x00437;&#x0044b; &#x0043d;&#x00435;&#x0043e;&#x00431;&#x00445;&#x0043e;&#x00434;&#x00438;&#x0043c;&#x0043e; &#x0043f;&#x00440;&#x00438;&#x0043d;&#x0044f;&#x00442;&#x0044c; &#x0043c;&#x00435;&#x00440;&#x0044b; &#x00434;&#x0043b;&#x0044f; &#x00443;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0044d;&#x00442;&#x00438;&#x00445; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043a;&#x0043e;&#x00432;.<bold/></p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Antibiotic resistance is a problem of global importance.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Representative data on the extent of the problem in low-and middle-income countries are relatively scarce, but high levels of resistance are increasingly being reported worldwide.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref><sup>&#x02013;</sup><xref rid="R4" ref-type="bibr"><sup>4</sup></xref> Misuse and overuse of antibiotics in humans and animals is one of the main drivers of antibiotic resistance.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R6" ref-type="bibr"><sup>6</sup></xref> Antibiotic stewardship, that is, interventions designed to optimize use of antibiotics, is therefore one of the key actions of the World Health Organization (WHO) Global Action Plan to contain antibiotic resistance.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R7" ref-type="bibr"><sup>7</sup></xref> Stewardship interventions are typically classified as structural (such as the introduction of new diagnostic tests to guide antibiotic treatment), persuasive (such as expert audit of prescriptions and feedback advice to prescribers), enabling (such as guidelines or education on antibiotic use) or restrictive (such as expert approval for use of certain antibiotics).<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> Often, different interventions are combined in antibiotic stewardship bundles.</p><p>Several systematic reviews showed that antibiotic stewardship interventions for hospitalized patients increased compliance with local antibiotic policies and improved clinical patient outcomes.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> These reviews included mainly or exclusively papers from high-income countries. Whether these results also apply to low- and middle-income countries is unclear. The organization of health-care system, availability of diagnostic testing and appropriate antibiotics, infection prevention and control practices and prescribing practices (such as over-the-counter availability of antibiotics) differs markedly between high-income countries and low- and middle-income countries.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> These differences may affect the implementation and effectiveness of antibiotic stewardship interventions in these settings.</p><p>Many hospitals in low- and middle-income countries are setting up antibiotic stewardship programmes.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> To better inform the selection of antibiotic stewardship interventions, we systematically reviewed the literature for studies that describe the effect of these interventions on clinical, microbiological or antibiotic prescribing outcomes in hospitalized patients in low- and middle-income countries.</p></sec><sec sec-type="methods"><title>Methods</title><p>The review protocol including the complete search strategy has been registered at the PROSPERO international prospective register of systematic reviews (CRD42016042019).<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p><p>We included studies on antibiotic stewardship interventions for hospitalized patients in low- and middle-income countries. Stewardship interventions were defined as any intervention aiming to improve appropriate prescribing of antibiotics. A summary of the search strategy is shown in <xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref>. Low- and middle-income countries were defined according to the World Bank criteria.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref> To be included, studies had to report at least one prescribing outcome (such as defined daily doses per 100 bed-days), clinical outcome (such as mortality) or microbiological outcome (such as proportion of bacterial isolates with antibiotic resistance). We included (non)randomized controlled trials, cluster randomized controlled trials, controlled before&#x02012;after studies and interrupted time-series studies if these contained at least three points of comparison pre-and post-intervention. Studies were excluded if they included residents of long-term health-care or nursing facilities; studied malaria, human immunodeficiency virus, mycobacterial or fungal infections, <italic>Helicobacter pylori</italic> eradication, or care pathways (such as malnutrition bundles); compared antibiotic regimens; were written in language other than English, Dutch, French, German, Portuguese or Spanish; or had no full-text article available.</p><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Search strategy for the review of antibiotic stewardship interventions in hospitals in low-and middle-income countries</title></caption><p>We searched the following databases from inception to 5 December 2017: Cochrane Central Register of Controlled Trials, EMBASE<sup>&#x000ae;</sup>, MEDLINE<sup>&#x000ae;</sup>, regional databases of the Global Index Medicus and the World Health Organization&#x02019;s Virtual Health Library. The combination of the following and related terms was used: &#x0201c;low- and middle-income country&#x0201d;, &#x0201c;antibiotic&#x0201d;, &#x0201c;stewardship&#x0201d;, &#x0201c;inpatient&#x0201d; and terms related to study design such as &#x0201c;clinical trial&#x0201d;, &#x0201c;randomized controlled trial&#x0201d;, &#x0201c;interrupted time series&#x0201d;, &#x0201c;controlled before after&#x0201d;. Syntax and wording was adapted to the different libraries. Moreover, we searched reference lists of selected studies and of relevant reviews and consulted experts for additional literature. The full search strategy can be viewed online.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p></boxed-text><p>Titles and abstracts were independently screened for eligibility by two authors. In case of disagreement, consensus was sought after reading the full-text article. The study selection was piloted by screening 630 abstracts and 44 full-text articles. These results were discussed among a panel of experts, after which the eligibility criteria were fine-tuned.</p><p>Two researchers extracted the data using an electronic form. The authors of original studies were not contacted in cases of incomplete or missing data. Data that were analysed inappropriately in the original studies were excluded. The quality of the studies was evaluated at the study level by two researchers independently. We used the 2017 quality criteria for randomized controlled trials and quasi-experimental studies of the Effective Practice and Organisation of Care Review Group.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> Reporting was done in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> For controlled trials, intention-to-treat analyses were reported unless indicated otherwise. If the original paper did not mention a relative risk (RR), we calculated a RR and 95% confidence interval (CI) if the necessary data were available. Due to the heterogeneity of the interventions and their reported outcomes, we present our findings using a narrative approach. Because of the large number of reported outcomes, we were unable to report all. We therefore selected the outcomes that were reported most frequently across the studies. We grouped studies by intervention type: structural, persuasive, enabling or intervention bundle.</p></sec><sec sec-type="results"><title>Results</title><p>We screened 7342 abstracts, selected 241 full-text articles and included 27 studies:<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> 12 interrupted time-series, 9 randomized controlled trials, 3 cluster randomized controlled trials and 3 non-randomized controlled trials (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). The studies were performed between 1996 and 2015 in 13 different countries. Two countries were considered low-income at the time of the study, one country transitioned from low to lower-middle income and the remaining were middle-income countries. Nine studies were conducted in multiple hospitals (range 2&#x02013;65) but the majority was single-centre (18 studies). The interventions were implemented hospital-wide (10 studies) or on specific wards (17 studies) and targeted therapeutic prescriptions (20 studies), surgical prophylaxis (3 studies) or a combination of those (4 studies; <xref ref-type="table" rid="T1">Table&#x000a0;1</xref>).</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart of the selection of studies included in the review of antibiotic stewardship interventions in hospitals in low-and middle-income countries</p></caption><graphic xlink:href="BLT.17.203448-F1"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Characteristics of studies included in the review of antibiotic stewardship interventions in hospitals in low-and middle-income countries</title></caption><table frame="hsides" rules="groups"><col width="104" span="1"/><col width="78" span="1"/><col width="62" span="1"/><col width="85" span="1"/><col width="92" span="1"/><col width="77" span="1"/><col width="170" span="1"/><col width="92" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study design</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Country</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Setting</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Participants</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Intervention type</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Intervention details</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Target illness</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Weinberg et al., 2001<xref rid="R39" ref-type="bibr"><sup>39</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Colombia</td><td valign="top" align="left" rowspan="1" colspan="1">2 referral hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Surgeons performing caesarean sections</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Guidelines on surgical antibiotic prophylaxis; structural changes (availability of prophylactic antibiotics on site); audit and feedback to physicians and nurses at hospital and individual level</td><td valign="top" align="left" rowspan="1" colspan="1">Surgical site infections after caesarean section</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Perez et al., 2003<xref rid="R40" ref-type="bibr"><sup>40</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Colombia</td><td valign="top" align="left" rowspan="1" colspan="1">2 university hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Hospital A: all prescribers; hospital B: anaesthesiologists</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Prescription form with (un)restricted antibiotics; educational campaign; reminders in the workplace</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">G&#x000fc;lmezoglu et al., 2007<xref rid="R27" ref-type="bibr"><sup>27</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cluster randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Mexico and Thailand</td><td valign="top" align="left" rowspan="1" colspan="1">22 non-university maternity hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Physicians, midwives, interns, students</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Access to WHO&#x02019;s online Reproductive Health Library<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> and workshops on its use</td><td valign="top" align="left" rowspan="1" colspan="1">Surgical site infections after caesarean section</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hadi et al., 2008<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Indonesia</td><td valign="top" align="left" rowspan="1" colspan="1">1 teaching hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers of 5 internal medicine wards</td><td valign="top" align="left" rowspan="1" colspan="1">Enabling</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic guidelines; education for prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000d6;zkaya et al., 2009<xref rid="R26" ref-type="bibr"><sup>26</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Non-randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Turkey</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Paediatric emergency department residents</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by influenza rapid test versus no laboratory investigation</td><td valign="top" align="left" rowspan="1" colspan="1">Mild influenza-like illness</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rattanaumpawan et al., 2010<xref rid="R32" ref-type="bibr"><sup>32</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Non-randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Thailand</td><td valign="top" align="left" rowspan="1" colspan="1">1 public university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Persuasive</td><td valign="top" align="left" rowspan="1" colspan="1">Audit and feedback to prescribers by infectious diseases specialist</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Long et al., 2011<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial </td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Emergency department physicians</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation and discontinuation guided by serum procalcitonin level versus routine care<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Community-acquired pneumonia</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Maravi&#x00107;-Stojkovi&#x00107; et al., 2011<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial </td><td valign="top" align="left" rowspan="1" colspan="1">Serbia</td><td valign="top" align="left" rowspan="1" colspan="1">1 tertiary hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Cardiac surgery and intensive care unit staff</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by serum procalcitonin level versus routine care (based on clinical signs, C-reactive protein levels and leukocyte count)</td><td valign="top" align="left" rowspan="1" colspan="1">Infections after coronary artery bypass grafting or valve surgery </td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Shen et al., 2011<xref rid="R33" ref-type="bibr"><sup>33</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cluster randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 tertiary hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers of 2 pulmonary wards</td><td valign="top" align="left" rowspan="1" colspan="1">Persuasive</td><td valign="top" align="left" rowspan="1" colspan="1">Audit and feedback to prescribers by clinical pharmacist</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory tract infections</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Opondo et al., 2011<xref rid="R37" ref-type="bibr"><sup>37</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Cluster randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td><td valign="top" align="left" rowspan="1" colspan="1">8 district hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Nurses, clinical and medical officers</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Guidelines for treatment of non-bloody diarrhoea; education for prescribers; audit and feedback to prescribers on hospital performance</td><td valign="top" align="left" rowspan="1" colspan="1">Non-bloody diarrhoea</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bucher et al., 2012<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Peru</td><td valign="top" align="left" rowspan="1" colspan="1">1 public hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Paediatric emergency department physicians</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by faecal rotavirus rapid test in combination with a faecal leukocyte test versus faecal leukocyte test only</td><td valign="top" align="left" rowspan="1" colspan="1">Acute diarrhoea</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Magedanz et al., 2012<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Brazil</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers of the cardiology department</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Restriction of certain antibiotics; audit and feedback to prescribers by (i) infectious diseases specialist and (ii) pharmacist</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Qu et al., 2012<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 municipal hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Intensive care unit staff</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation and discontinuation guided by serum procalcitonin level versus standard 14 days of antibiotics</td><td valign="top" align="left" rowspan="1" colspan="1">Severe acute pancreatitis</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ding et al., 2013<xref rid="R17" ref-type="bibr"><sup>17</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 tertiary hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory ward physicians</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation and discontinuation guided by serum procalcitonin level versus routine care (based on clinical experience, sputum bacteriology results and leukocyte count)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute exacerbation of idiopathic pulmonary fibrosis</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Aiken et al., 2013<xref rid="R36" ref-type="bibr"><sup>36</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Kenya</td><td valign="top" align="left" rowspan="1" colspan="1">1 public referral hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Nursing, medical and operating theatre staff</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Guidelines on surgical antibiotic prophylaxis; clinician education; patient education posters; audit and feedback to prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Surgical site infections</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Oliveira et al., 2013<xref rid="R23" ref-type="bibr"><sup>23</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial </td><td valign="top" align="left" rowspan="1" colspan="1">Brazil</td><td valign="top" align="left" rowspan="1" colspan="1">2 public university hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Intensive care unit staff</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic discontinuation guided by serum procalcitonin level versus C-reactive protein test</td><td valign="top" align="left" rowspan="1" colspan="1">Sepsis or septic shock</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tang et al., 2013<xref rid="R21" ref-type="bibr"><sup>21</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Emergency department physicians</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by serum procalcitonin level versus routine carea</td><td valign="top" align="left" rowspan="1" colspan="1">Acute asthma exacerbation</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chandy et al., 2014<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">India</td><td valign="top" align="left" rowspan="1" colspan="1">1 private tertiary hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Enabling</td><td valign="top" align="left" rowspan="1" colspan="1">Implementation and dissemination of antibiotic prescribing guidelines</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Long et al., 2014<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Emergency department physicians</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by serum procalcitonin level versus routine care<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Acute asthma exacerbation</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Najafi et al., 2015<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">Islamic Republic of Iran</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Intensive care unit staff</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic initiation guided by serum procalcitonin level versus routine care<sup>a</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Severe inflammatory response syndrome</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bao et al., 2015<xref rid="R42" ref-type="bibr"><sup>42</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">65 public hospitals (30 tertiary; 35 secondary)</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Implementation of a nationally imposed multifaceted antibiotic stewardship programme</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sun et al., 2015<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">15 public tertiary hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Implementation of a nationally imposed multifaceted antibiotic stewardship programme</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gong et al., 2016<xref rid="R38" ref-type="bibr"><sup>38</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">1 tertiary paediatric hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Paediatricians</td><td valign="top" align="left" rowspan="1" colspan="1">Bundle</td><td valign="top" align="left" rowspan="1" colspan="1">Antibiotic guidelines and prescribing restrictions; audit and feedback to prescribers by pharmacists and infection control physicians; financial penalties according to number of noncompliant prescriptions</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Brink et al., 2016<xref rid="R29" ref-type="bibr"><sup>29</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">South Africa</td><td valign="top" align="left" rowspan="1" colspan="1">47 private hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Physicians, other clinical staff and managers</td><td valign="top" align="left" rowspan="1" colspan="1">Persuasive</td><td valign="top" align="left" rowspan="1" colspan="1">Audit and feedback to prescribers by a pharmacist</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Li et al., 2017<xref rid="R30" ref-type="bibr"><sup>30</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Non-randomized controlled trial</td><td valign="top" align="left" rowspan="1" colspan="1">China</td><td valign="top" align="left" rowspan="1" colspan="1">6 university hospitals</td><td valign="top" align="left" rowspan="1" colspan="1">Physicians of 8 intensive care units</td><td valign="top" align="left" rowspan="1" colspan="1">Persuasive</td><td valign="top" align="left" rowspan="1" colspan="1">Audit and feedback to prescribers by a pharmacist versus no intervention</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tuon et al., 2017<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">Brazil</td><td valign="top" align="left" rowspan="1" colspan="1">1 university hospital</td><td valign="top" align="left" rowspan="1" colspan="1">All prescribers</td><td valign="top" align="left" rowspan="1" colspan="1">Structural</td><td valign="top" align="left" rowspan="1" colspan="1">Mobile phone application providing antibiotic prescribing guidance</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wattal et al., 2017<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Interrupted time-series</td><td valign="top" align="left" rowspan="1" colspan="1">India</td><td valign="top" align="left" rowspan="1" colspan="1">1 tertiary hospital</td><td valign="top" align="left" rowspan="1" colspan="1">Surgeons of 45 units</td><td valign="top" align="left" rowspan="1" colspan="1">Persuasive</td><td valign="top" align="left" rowspan="1" colspan="1">Audit and feedback to prescribers; focus group discussions per specialty</td><td valign="top" align="left" rowspan="1" colspan="1">NR</td></tr></tbody></table><table-wrap-foot><p>NR:&#x02009;not reported; WHO:&#x02009;World Health Organization.</p><p><sup>a</sup> The content of routine care was not specified.</p></table-wrap-foot></table-wrap><sec><title>Risk of bias assessment</title><p>For the 12 interrupted time-series studies the risk of bias was low (3 studies), medium (8 studies) or high (1 study; <xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>). The main risks of bias were that the intervention was not independent of other changes (5 studies) and that incomplete data were not adequately addressed (5 studies). For the 15 (non)randomized trials the risk of bias was medium (3 studies) or high (12 studies). The main risks of bias included the absence of baseline outcome measurement (14 studies), lack of protection against contamination (prescribers could have been involved in treatment of both the intervention and control group; 11 studies), non-random or unclear randomization methods (8 studies) and incomplete data not being adequately addressed (7 studies).</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Assessment of risk of bias in studies included in the review of antibiotic stewardship interventions in hospitals in low-and middle-income countries</p></caption><p><sup>a</sup> The criteria were: A: intervention independent of other changes; B: shape of intervention pre-specified; C: intervention unlikely to affect data collection; D: knowledge of allocated interventions adequately prevented during study; E: seasonality taken into account; F: incomplete outcome data adequately addressed; G: study free from selective outcome reporting; H: adequate allocation sequencing; I: adequate allocation concealment; J: baseline outcome measures similar; K: baseline characteristics similar; L: any blinding reported; M: study protected against contamination.</p><p><sup>b</sup> The risk of bias was considered low if all criteria were scored as low, medium if one or two criteria were scored as medium or high, and high if more than two criteria were scored as medium or high.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><graphic xlink:href="BLT.17.203448-F2"/></fig></sec><sec><title>Structural interventions</title><p>Structural interventions were reported by 12 studies,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R28" ref-type="bibr"><sup>28</sup></xref> eight of which were randomized controlled trials of the effect of using serum procalcitonin levels to guide antibiotic treatment (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref> Five of these studies reported antibiotic use as the outcome. All of them found a significant decrease in the percentage of patients receiving antibiotics in the procalcitonin group compared with routine care or C-reactive protein testing. RR ranged between 0.40 and 0.87.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Five studies reported patient deaths as the outcome and found no significant effect of procalcitonin-guided antibiotic use on in-hospital or 30-day mortality.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref><sup>&#x02013;</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Outcomes of interventions to improve appropriate prescribing and use of antibiotics in hospitals in low-and middle-income countries: controlled trials</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="62" span="1"/><col width="62" span="1"/><col width="173" span="1"/><col width="93" span="1"/><col width="91" span="1"/><col width="49" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Intervention type and study design </th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study duration, weeks</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of patients</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Data summary</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Outcome measure</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Effect size</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Structural intervention</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Procalcitonin guidance</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">201</td><td valign="top" align="center" rowspan="1" colspan="1">172</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 72/86 in procalcitonin group; 79/86 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.87 (0.79 to 0.96)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></td><td rowspan="2" valign="top" align="center" colspan="1">NR</td><td rowspan="2" valign="top" align="center" colspan="1">205</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 19/102 in procalcitonin group; 48/103 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.40 (0.25 to 0.63)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">No. of deaths: 3/102 in procalcitonin group; 3/103 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of in-hospital death (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.33 to 2.35)</td><td valign="top" align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R17" ref-type="bibr"><sup>17</sup></xref></td><td rowspan="2" valign="top" align="center" colspan="1">154</td><td rowspan="2" valign="top" align="center" colspan="1">78</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 26/39 in procalcitonin group; 35/39 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.74 (0.58 to 0.95)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">No. of deaths: 21/39 in procalcitonin group; 20/39 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of death after 30 days<sup>a</sup> (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">1.11 (0.76 to 1.64)</td><td valign="top" align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="left" rowspan="1" colspan="1">No. of deaths: 7/35 in procalcitonin group; 8/36 in standard 14 days of antibiotics group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of in-hospital death (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.37 to 2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">0.99</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R23" ref-type="bibr"><sup>23</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">141</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="left" rowspan="1" colspan="1">No. of deaths: 21/50 in procalcitonin group; 21/47 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of in-hospital death (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.92 (0.59 to 1.44)</td><td valign="top" align="center" rowspan="1" colspan="1">0.84</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R21" ref-type="bibr"><sup>21</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">283</td><td valign="top" align="center" rowspan="1" colspan="1">265</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 59/132 in procalcitonin group; 95/133 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.63 (0.50 to 0.78)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td valign="top" align="center" rowspan="1" colspan="1">180</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 44/90 in procalcitonin group; 79/90 in routine care group </td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.56 (0.44 to 0.70)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="left" rowspan="1" colspan="1">No. of deaths: 5/30 in procalcitonin group; 4/30 in routine care group</td><td valign="top" align="left" rowspan="1" colspan="1">RR of in-hospital death (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">1.25 (0.37 to 4.21)</td><td valign="top" align="center" rowspan="1" colspan="1">0.71</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Rapid diagnostic testing</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Non-randomized controlled trial<xref rid="R26" ref-type="bibr"><sup>26</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 34/50 in influenza rapid diagnostic test group; 47/47 in routine care group </td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.68 (0.56 to 0.82)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Randomized controlled trial<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">26</td><td valign="top" align="center" rowspan="1" colspan="1">201</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics: 29/100 in faecal leukocyte + rotavirus rapid test group; 50/101 in faecal leukocyte test only group </td><td valign="top" align="left" rowspan="1" colspan="1">RR of receiving antibiotic (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">0.59 (0.41 to 0.84)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Library access plus workshops</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">Cluster randomized controlled trial<xref rid="R27" ref-type="bibr"><sup>27</sup></xref></td><td rowspan="2" valign="top" align="center" colspan="1">43 to 52<sup>b</sup></td><td rowspan="2" valign="top" align="center" colspan="1">1000 to 1022 per hospital</td><td rowspan="2" valign="top" align="left" colspan="1">Mean % of operations with antibiotic prophylaxis:<break/>Mexico: 25.8 in intervention group; 6.5 in control group Thailand: 26.0 in intervention group; 14.7 in control group</td><td rowspan="2" valign="top" align="left" colspan="1">% of operations with antibiotic prophylaxis: difference in adjusted rate (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">Mexico: 19 (&#x02212;8 to 46)</td><td valign="top" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Thailand: 5 (&#x02212;18 to 27)</td><td valign="top" align="center" rowspan="1" colspan="1">0.66</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Persuasive intervention</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Audit and feedback on individual patient cases</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">&#x000a0;&#x000a0;Non-randomized controlled trial<xref rid="R32" ref-type="bibr"><sup>32</sup></xref></td><td rowspan="2" valign="top" align="center" colspan="1">17</td><td rowspan="2" valign="top" align="center" colspan="1">948</td><td valign="top" align="left" rowspan="1" colspan="1">Mean no. of days of hospitalization: 30.4 in intervention group; 30.7 in control group</td><td valign="top" align="left" rowspan="1" colspan="1">Mean difference in hospital length of stay (95% CI), days </td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.3 (&#x02212;3.3 to &#x02212;3.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Mean no. of days of treatment: 12.7 in intervention group; 16.4 in control group</td><td valign="top" align="left" rowspan="1" colspan="1">Mean difference in treatment duration, days</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;3.7 (&#x02212;5.2 to &#x02212;2.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Cluster randomized controlled tria<xref rid="R33" ref-type="bibr"><sup>33</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">436</td><td valign="top" align="left" rowspan="1" colspan="1">Mean no. of days of hospitalization: 14.2 in intervention group; 15.8 in control group</td><td valign="top" align="left" rowspan="1" colspan="1">Mean difference in hospital length of stay (95% CI), days </td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.6 (&#x02212;2.9 to &#x02212;0.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Non-randomized controlled trial<xref rid="R30" ref-type="bibr"><sup>30</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">874</td><td valign="top" align="left" rowspan="1" colspan="1">Median no. of days of treatment: 4.0 in intervention group; 5.0 in control group</td><td valign="top" align="left" rowspan="1" colspan="1">Difference in median no. of days of treatment</td><td valign="top" align="center" rowspan="1" colspan="1">1.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Intervention bundle</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Treatment guidelines plus education plus audit and feedback</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;Cluster randomized controlled trial<xref rid="R37" ref-type="bibr"><sup>37</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">77</td><td valign="top" align="center" rowspan="1" colspan="1">1160</td><td valign="top" align="left" rowspan="1" colspan="1">No. of patients receiving antibiotics for inappropriate indication: 313/594 in intervention group; 437/566 in control group</td><td valign="top" align="left" rowspan="1" colspan="1">Absolute risk reduction for receiving antibiotic for inappropriate indication (95% CI)</td><td valign="top" align="center" rowspan="1" colspan="1">41 (&#x02212;6 to 88)</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; DDD: defined daily doses; NR: not reported; RR: relative risk.</p><p><sup>a</sup> Per protocol analysis.</p><p><sup>b</sup> Different collection periods in different hospitals.</p><p>Note: Intention-to-treat analysis results are reported unless indicated otherwise. When significant <italic>P</italic>-values were not specified, we assumed <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 as significant.</p></table-wrap-foot></table-wrap><p>A non-randomized controlled trial among 97 patients in a Turkish emergency department studied the effect of introducing a rapid diagnostic test for influenza-like disease.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> A lower percentage of tested patients were prescribed antibiotics compared with patients given clinical examination only (RR: 0.68; 95% CI: 0.56 to 0.82). In a randomized controlled trial among 201 patients in a Peruvian emergency department, use of a rapid test for rotavirus was associated with fewer patients receiving antibiotics (RR: 0.59; 95% CI: 0.41 to 0.84).<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></p><p>In a cluster-randomized controlled trial in Mexico and Thailand health-care staff were given access to the WHO&#x02019;s online Reproductive Health Library and workshops on its use.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Thereafter, it was left open to the 22 participating hospitals whether certain activities, including antibiotic stewardship, were implemented. After 10&#x02012;12 months, no significant difference was found in the proportion of caesarean sections in which antibiotic prophylaxis was given, when comparing the 22 intervention hospitals to the 18 control hospitals (difference in adjusted rate in Mexico was 19.0%; 95% CI: &#x02212;8.0 to 46.0% and in Thailand was 4.6%; 95% CI: &#x02212;17.7 to 26.9%).</p><p>One interrupted time-series study evaluated the implementation of an antibiotic treatment guide through a free-of-charge mobile application (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). Twenty-four months after the intervention there were significant increases in the defined daily doses per 1000 bed-days of recommended antibiotics (amikacin and cefepime) and a significant decrease in non-recommended antibiotics (piperacillin; <italic>P</italic>&#x02009;=&#x02009;0.02). Use of other non-recommended antibiotics (meropenem, ciprofloxacin and polymyxin) did not decrease significantly.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Outcomes of interventions to improve appropriate prescribing and use of antibiotics in hospitals in low-and middle-income countries: interrupted time-series studies</title></caption><table frame="hsides" rules="groups"><col width="86" span="1"/><col width="89" span="1"/><col width="120" span="1"/><col width="77" span="1"/><col width="177" span="1"/><col width="42" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Intervention</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study segments (duration in weeks)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of data points per segment (no. of observations per data point)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Outcome measure</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Effect size<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Structural interventions</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" valign="top" align="left" scope="row" colspan="1">Mobile phone application<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">S1: Pre-intervention (52)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (NR)</td><td rowspan="7" valign="top" align="left" colspan="1">DDD per 1000 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline trend NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="6" valign="top" colspan="1" align="left" scope="row">S2: Post-intervention (52)</td><td rowspan="6" valign="top" align="center" colspan="1">12 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Trend increased for amikacin<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend increased for cefepime<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend decreased for piperacillin<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend decreased for meropenem<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend decreased for polymyxin<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend decreased for ciprofloxacin<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Persuasive interventions</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="6" valign="top" align="left" scope="row" colspan="1">Audit and feedback on individual patient cases<xref rid="R29" ref-type="bibr"><sup>29</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (70)</td><td rowspan="2" valign="top" align="center" colspan="1">16 (NR)</td><td rowspan="6" valign="top" align="left" colspan="1">DDD per 100 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend +0.064/month</td><td valign="top" align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Implementation (104)</td><td rowspan="2" valign="top" align="center" colspan="1">24 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change &#x02212;0.56/month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (86)</td><td rowspan="2" valign="top" align="center" colspan="1">20 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change &#x02212;0.20/month</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="3" valign="top" align="left" scope="row" colspan="1">Audit and feedback at department level<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (NR)</td><td rowspan="3" valign="top" align="left" colspan="1">DDD per 100 bed-days </td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: increasing in 1/35 wards<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">S2: Post-intervention (13)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level decreased in 3/35 wards<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Enabling interventions</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="10" valign="top" align="left" scope="row" colspan="1">Treatment guidelines<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (16)</td><td rowspan="2" valign="top" align="center" colspan="1">9 (14)</td><td rowspan="10" valign="top" align="left" colspan="1">DDD per 100 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: &#x02212;1.0 per 14 days</td><td valign="top" align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline development (14)</td><td rowspan="2" valign="top" align="center" colspan="1">6 (14)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;31.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change +2.1 per 14 days</td><td valign="top" align="center" rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Guideline declaration (8)</td><td rowspan="2" valign="top" align="center" colspan="1">4 (26)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;29.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;9.5 per 14 days</td><td valign="top" align="center" rowspan="1" colspan="1">0.14</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S4: Teaching sessions (8)</td><td rowspan="2" valign="top" align="center" colspan="1">4 (27)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +38.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +10.0 per 14 days</td><td valign="top" align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S5: Refresher course (8)</td><td rowspan="2" valign="top" align="center" colspan="1">5 (15)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;2.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;9.8 per 14 days</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td rowspan="10" valign="top" align="left" scope="row" colspan="1">Treatment guidelines<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (86)</td><td rowspan="2" valign="top" align="center" colspan="1">20 (NR)</td><td rowspan="10" valign="top" align="left" colspan="1">DDD per 100 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 56.9</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: +0.95 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline preparation and booklet dissemination (94)</td><td rowspan="2" valign="top" align="center" colspan="1">22 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +0.21 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: No new intervention (104)</td><td rowspan="2" valign="top" align="center" colspan="1">24 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +0.31 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S4: Guideline revision and booklet dissemination (104)</td><td rowspan="2" valign="top" align="center" colspan="1">24 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +0.05 per month&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S5: Guideline revision and booklet with electronic dissemination (86)</td><td rowspan="2" valign="top" align="center" colspan="1">20 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;0.37 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Intervention bundles</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="35" valign="top" align="left" scope="row" colspan="1">Treatment guidelines plus structural changes<xref rid="R39" ref-type="bibr"><sup>39</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Hospital A</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (13)</td><td rowspan="2" valign="top" align="center" colspan="1">3 (308)</td><td rowspan="6" valign="top" align="left" colspan="1">% of operations with surgical site infection</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 13.9</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline introduction with structural changes (30)</td><td rowspan="2" valign="top" align="center" colspan="1">7 (272)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;9.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (21)</td><td rowspan="2" valign="top" align="center" colspan="1">5 (217)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Hospital A</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (13)</td><td rowspan="2" valign="top" align="center" colspan="1">3 (308)</td><td rowspan="6" valign="top" align="left" colspan="1">% of caesarean sections with administration of antibiotic prophylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 47.5</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline introduction with structural changes (30)</td><td rowspan="2" valign="top" align="center" colspan="1">7 (272)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +31.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (21)</td><td rowspan="2" valign="top" align="center" colspan="1">5 (217)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;4.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Hospital B:</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (13)</td><td rowspan="2" valign="top" align="center" colspan="1">3 (396)</td><td rowspan="6" valign="top" align="left" colspan="1">% of caesarean sections with administration of antibiotic prophylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 5.1</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline introduction with structural changes (39)</td><td rowspan="2" valign="top" align="center" colspan="1">9 (1026)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +5.4 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (709)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +7.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;4.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Hospital A</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (13)</td><td rowspan="2" valign="top" align="center" colspan="1">3 (308)</td><td rowspan="6" valign="top" align="left" colspan="1">% of caesarean sections with administration of antibiotic prophylaxis within 1 hour of delivery</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 32.5</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline introduction with structural changes (30)</td><td rowspan="2" valign="top" align="center" colspan="1">7 (272)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: 62.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (21)</td><td rowspan="2" valign="top" align="center" colspan="1">5 (217)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Hospital B</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (13)</td><td rowspan="2" valign="top" align="center" colspan="1">3 (396)</td><td rowspan="6" valign="top" align="left" colspan="1">% of caesarean sections with administration of antibiotic prophylaxis within 1 hour of delivery</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 30.8</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: +18.4 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guideline introduction with structural changes (39)</td><td rowspan="2" valign="top" align="center" colspan="1">9 (1026)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;18.7 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (709)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +15.2</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1">Prescription form plus education plus reminders<xref rid="R40" ref-type="bibr"><sup>40</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (103)</td><td rowspan="2" valign="top" align="center" colspan="1">103 (NR)</td><td rowspan="4" valign="top" align="left" colspan="1">% of operations with incorrect timing of antibiotic prophylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Post-intervention (42)</td><td rowspan="2" valign="top" align="center" colspan="1">42 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;20</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td></tr><tr><td rowspan="6" valign="top" align="left" scope="row" colspan="1">Antibiotic restrictions plus audit and feedback<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (129)</td><td rowspan="2" valign="top" align="center" colspan="1">30 (NR)</td><td rowspan="6" valign="top" align="left" colspan="1">Antibiotic use, DDD per 100 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend +1.2 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Antibiotic restrictions plus audit and feedback by infectious diseases specialist (94)</td><td rowspan="2" valign="top" align="center" colspan="1">22 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;2.7 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Antibiotic restrictions plus audit and feedback by pharmacist (86)</td><td rowspan="2" valign="top" align="center" colspan="1">20 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +4.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +1.2 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="10" valign="top" align="left" scope="row" colspan="1">Treatment guidelines plus education plus audit and feedback<xref rid="R36" ref-type="bibr"><sup>36</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Timing study</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (26)</td><td rowspan="2" valign="top" align="center" colspan="1">26 (NR)</td><td rowspan="4" valign="top" align="left" colspan="1">% of operations with incorrect timing of antibiotic prophylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 99%</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Post-intervention (40)</td><td rowspan="2" valign="top" align="center" colspan="1">40 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level decreased<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend decreased<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Infection study</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (26)</td><td rowspan="2" valign="top" align="center" colspan="1">6 (223)</td><td rowspan="4" valign="top" align="left" colspan="1">% of operations with surgical site infection</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: &#x02212;0.5 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.49</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Post-intervention (39)</td><td rowspan="2" valign="top" align="center" colspan="1">9 (223)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: NR</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;0.7 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="14" valign="top" align="left" scope="row" colspan="1">Multifaceted antibiotic stewardship programme<xref rid="R42" ref-type="bibr"><sup>42</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Outcome A</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (NR)</td><td rowspan="6" valign="top" align="left" colspan="1">% of patients receiving antibiotic</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend +0.3 per month</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;&#x02009;0.05</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Implementation (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;2.3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;&#x02009;0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;2.3 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (104)</td><td rowspan="2" valign="top" align="center" colspan="1">24 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;2.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +1.9 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><italic>Outcome B</italic></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S1: Pre-intervention (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (NR)</td><td rowspan="6" valign="top" align="left" colspan="1">Antibiotic use, DDD per 100 bed-days</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: NR</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: &#x02212;0.4 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.2</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Implementation (52)</td><td rowspan="2" valign="top" align="center" colspan="1">12 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +2.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003e;&#x02009;0.05</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;2.2 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Post-intervention (104)</td><td rowspan="2" valign="top" align="center" colspan="1">24 (NR)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;7.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +2.4 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1">Multifaceted antibiotic stewardship programme<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (334)</td><td rowspan="2" valign="top" align="center" colspan="1">26 (58)</td><td rowspan="4" valign="top" align="left" colspan="1">% of patients receiving antibiotic</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 74.7</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: &#x02212;0.3 per quarter</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Post-intervention (78)</td><td rowspan="2" valign="top" align="center" colspan="1">6 (750)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;7.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;1.5 per quarter</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td rowspan="6" valign="top" align="left" scope="row" colspan="1">Treatment guidelines plus antibiotic restrictions plus audit and feedback<xref rid="R38" ref-type="bibr"><sup>38</sup></xref></td><td rowspan="2" valign="top" align="left" colspan="1">S1: Pre-intervention (17)</td><td rowspan="2" valign="top" align="center" colspan="1">4 (375&#x0202f;985)</td><td rowspan="6" valign="top" align="left" colspan="1">% of patients receiving antibiotic</td><td valign="top" align="left" rowspan="1" colspan="1">Baseline level: 59.0</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Baseline trend: &#x02212;3.0 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S2: Guidelines and restrictions (21)</td><td rowspan="2" valign="top" align="center" colspan="1">5 (424&#x0202f;702)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: +3.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.2</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: &#x02212;0.4 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td rowspan="2" valign="top" colspan="1" align="left" scope="row">S3: Financially punished audit and feedback (60)</td><td rowspan="2" valign="top" align="center" colspan="1">14 (446&#x0202f;727)</td><td valign="top" colspan="1" align="left" rowspan="1">Level change: &#x02212;9.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Trend change: +3.0 per month</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td></tr></tbody></table><table-wrap-foot><p>DDD: defined daily doses; N/A: not applicable; NR: not reported; RR: relative risk; S: segment.</p><p><sup>a</sup> In interrupted times-series studies the linear curve which summarizes the outcome data in each study segment can be defined by its level (<italic>y</italic>-intercept) and trend (slope). Level change reflects the difference of the level of the current segment compared with the level of the previous segment. Trend change reflects the difference of the trend of the current segment compared to the trend of the previous segment.</p><p><sup>b</sup> The authors reported no values for level or trend changes.</p><p><sup>c</sup> The authors reported that there were no significant changes but with no values for levels or trend changes.</p></table-wrap-foot></table-wrap></sec><sec><title>Persuasive interventions</title><p>Four studies evaluated the effect of audit and feedback to prescribers on individual patient cases by pharmacists (3 studies) or infectious diseases specialists (1 study):<xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="R30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="R32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> A non-randomized controlled trial including 577 patients in eight intensive care units reported a decrease of duration of antibiotic treatment of &#x02212;1.0&#x000a0;day (<italic>P</italic>&#x02009;=&#x02009;0.03) (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> Another non-randomized controlled trial of 948 patients in a public university hospital reported a decrease of duration on antibiotic treatment of &#x02212;3.7&#x000a0;days (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) and a decrease in mean length of hospital stay of &#x02212;1.6&#x000a0;days (<italic>P</italic>&#x02009;=&#x02009;0.03).<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> A cluster randomized trial found no significant difference in mean length of hospital stay among 436 patients (0.3&#x000a0;days; <italic>P</italic>&#x02009;=&#x02009;0.8).<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> An interrupted time-series study in 47 private hospitals in South Africa found a decreasing trend of antibiotic use during the implementation phase of the intervention (&#x02212;0.56 defined daily doses per 100 bed-days per month; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; <xref ref-type="table" rid="T3">Table&#x000a0;3</xref>).<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> The trend was sustained in the 20 months post-implementation (&#x02212;0.20 defined daily doses per 100 bed-days per month; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>An interrupted time-series study evaluated the effect of audit and feedback at the departmental level in 35 surgical wards. Three months after the intervention a significant decrease in defined daily doses per 100 bed-days was reported in 3 out of 35 wards (immediate decreases of &#x02212;66.5%, &#x02212;46.1% and &#x02212;26.4% respectively; <italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.05).<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></p></sec><sec><title>Enabling interventions</title><p>Two interrupted time-series studied the effect of enabling interventions on antibiotic prescribing (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>).<xref rid="R34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> A study in an Indonesian hospital subsequently studied the development of treatment guidelines which were officially presented, followed by education and then refresher education. The authors reported a significant decrease of &#x02212;31.9 defined daily doses per 100 bed-days (<italic>P</italic>&#x0202f;&#x02009;=&#x02009;&#x0202f;0.03) after guideline development and a significant increase of +38.2 defined daily doses per 100 bed-days (<italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.05) after education. The net effect of the intervention remains unclear.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref> Another study in an Indian hospital evaluated the effect of an antibiotic policy guideline which was first developed and introduced, then revised and made available as booklet and lastly revised and made available through the intranet. The authors initially reported a baseline rising trend in antibiotic use of +0.95 defined daily doses per 100 bed-days per month (<italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01) which levelled off after the first two interventions and declined by &#x02212;0.37 defined daily doses per 100 bed-days per month (<italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01) after the last intervention.<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></p></sec><sec><title>Intervention bundles</title><p>Eight studies evaluated bundles combining different interventions.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>&#x02013;</sup><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> A cluster randomized controlled trial in eight Kenyan hospitals compared a bundle containing guidelines, education and face-to-face feedback to prescribers with a similar, but less intensive bundle (fewer hours of training, written feedback; <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> Comparing prescriptions for 594 children in intervention hospitals and 566 children in control hospitals showed that the intensive bundle was associated with a non-significant absolute risk reduction in inappropriate use of antibiotics for non-bloody diarrhoea of 41% (95% CI: &#x02212;6 to 88%).</p><p>The other seven studies all used an interrupted time-series design (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). One study in two Colombian hospitals implemented antibiotic prophylaxis guidelines for caesarean sections, immediate availability of antibiotics in the operating theatre and feedback to surgeons about surgical site infections.<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> The study reported a significant increase in the percentage of caesarean section births in which prophylaxis was administered (immediate increase by +31.6% in hospital A; <italic>P</italic>&#x02009;&#x0003c;&#x02009;&#x0202f;0.01 and gradual increase by +5.4% per month in hospital B; <italic>P</italic>&#x02009;&#x0003c;&#x02009;&#x0202f;0.01), an increase in antibiotic administration within 1&#x000a0;hour of delivery (immediate increase by 62.2% in hospital A only; <italic>P</italic>&#x02009;&#x0003c;&#x02009;&#x0202f;0.01) and a significant decrease in the monthly rate of surgical site infections with 9.8% (<italic>P</italic>&#x02009;&#x0003c;&#x02009;&#x0202f;0.01) in hospital A. </p><p>In another study in a Kenyan hospital, surgical antibiotic prophylaxis guidelines were implemented, combined with training, personal feedback to prescribers and patient information posters.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> The proportion of operations with incorrect timing of antibiotic prophylaxis significantly decreased (no values reported) and the percentage of surgical site infections decreased after the intervention by &#x02212;0.7% per month (<italic>P&#x0202f;&#x02009;=</italic>&#x02009;&#x0202f;0.03).</p><p>Another Colombian study introduced an antibiotic prescription form containing a list of restricted antibiotics with information on dosing intervals and an educational campaign.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> The study found a decrease of 20% (<italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01) in the proportion of operations with incorrect timing of surgical prophylaxis.</p><p>In a Chinese study, guidelines and antibiotic restrictions were introduced, followed by individual prescriber audit and feedback, with financial penalties and revocation of prescribing privileges in case of non-compliance.<xref rid="R38" ref-type="bibr"><sup>38</sup></xref> Before the intervention the proportion of patients on antibiotic treatment was decreasing significantly by &#x02212;3% per month from a baseline level of 59% (<italic>P</italic>&#x0202f;&#x02009;=&#x02009;&#x0202f;0.01). After the first intervention, no significant changes were reported. After the second intervention, a sudden drop of &#x02212;9% (<italic>P</italic>&#x0202f;&#x02009;=&#x02009;&#x0202f;0.01) was observed, followed by a steady increase of +3% per month (<italic>P</italic>&#x0202f;&#x02009;=&#x02009;&#x0202f;0.01) in the next 14&#x000a0;months. The net effect of the intervention bundle remains unclear. </p><p>A study in a Brazilian cardiology hospital first introduced restriction of certain antibiotics with individual audit and feedback to prescribers by an infectious diseases specialist and subsequently more comprehensive audit and feedback by a pharmacist. Before the intervention, the total antibiotic consumption significantly increased during 30 months (+1.2 defined daily doses per 100 bed-days per month; <italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01). This trend decreased after the first intervention (&#x02212;2.7 per month; <italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01) and increased after the second (+1.2 per month; <italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01). The net effect of the intervention bundle remains unclear.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></p><p>Two Chinese studies looked at the implementation of a multifaceted national antibiotic stewardship programme, containing structural changes, antibiotic restriction, education, guidelines, and audit and feedback, in 65 and 15 secondary and tertiary public hospitals respectively.<xref rid="R42" ref-type="bibr"><sup>42</sup></xref><sup>,</sup><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> Participation was compulsory and financial punishment for hospitals and disciplinary actions for individual prescribers could be imposed. Both studies reported a significant decrease in antibiotic use after the intervention. One study reported a decreasing trend of &#x02212;2.2 defined daily doses per 100 bed-days per month (<italic>P</italic>&#x0202f; &#x0003c;&#x02009;&#x0202f;0.01).<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> The other study reported a decrease in the proportion of patients receiving antibiotics (&#x02212;7.3%; <italic>P</italic>&#x0202f;&#x02009;=&#x02009;&#x0202f;0.04).<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></p></sec><sec><title>Discussion</title><p>In this systematic review the majority of the included studies reported a positive effect of antibiotic stewardship interventions for hospitalized patients. This is in line with previously published systematic reviews on stewardship interventions in hospitals, which did not focus specifically on low- and middle-income countries.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> However, we cannot make general recommendations to guide the selection of antibiotic stewardship interventions due to limitations of the included studies, including the low quality of methods, variations and shortcomings in outcome reporting, under-representation of certain settings, heterogeneity of the interventions and variations in implementation strategy.</p><p>When screening titles and abstracts, we found 153 articles that reported on stewardship activities in a hospital setting, but 126 of those were excluded because of the study design (mainly bias-prone uncontrolled before&#x02012;after studies). So, although antibiotic stewardship is taking place and is being studied in low- and middle-income countries, most studies fall short methodologically. The studies we did include were also generally of low quality. For those with a randomized study design, a major risk of bias was contamination, meaning that prescribers could be involved in treatment of both the intervention and control groups. Because it may not be feasible to randomize individual prescribers, wards or hospitals to overcome this bias, interrupted time-series design has been recommended as an alternative. In interrupted time-series, data are collected continuously, and trends and outcome levels are compared before and after the intervention. To minimize bias and confounding, interrupted-time-series should meet certain requirements: a minimum of 12 data points before and after intervention, 100 observations per data point and the use of analytic techniques or models.<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> These requirements were seldom met by the included studies. Poor quality of methods is a consistent theme among reviews of antibiotic stewardship in countries of all income levels and this issue needs to be addressed to strengthen the evidence base.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="R46" ref-type="bibr"><sup>46</sup></xref></p><p>Many of the included studies focused on a quantitative reduction in antibiotic prescribing. However, stewardship is not merely concerned with a reduction in antibiotic use, but in finding the balance between the potency of antibiotics and their potentially hazardous effects. The goal is to improve patient outcomes, decrease antibiotic resistance and increase cost&#x02012;effectiveness of care. Therefore, it is recommended that clinical outcomes (including adverse events), microbiological and cost&#x02012;effectiveness outcomes are reported in all stewardship studies.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> Most of the studies included in this review failed to do so. There is an ongoing debate about which parameters should be reported to accurately reflect the above-mentioned outcomes.<xref rid="R48" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="R49" ref-type="bibr"><sup>49</sup></xref> This generally leads to a wide variety of reported parameters, as we observed in our review. This lack of uniformity limits comparison and aggregation of data. Also, for low- and middle-income settings, the measurement of certain clinical or microbiological outcomes, for example infection with <italic>Clostridium difficile</italic>, may be challenging if not impossible. Defining feasible outcome measures that can be uniformly applied in low- and middle-income countries should be prioritized. In the meantime, parameters that are easy to assess, such as mortality or hospital length of stay, should be reported by every stewardship study.</p><p>The majority of studies were performed in tertiary care centres in urban areas in middle-income countries, which limits the generalizability of the results. Large differences exist in terms of resources, organization, prescription practices and financing between countries and between facilities within countries.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> The intervention most frequently studied in our review was the implementation of procalcitonin testing. Although this intervention showed promising results, it may not be feasible to implement in many health-care settings in low- and middle-income countries. In addition, good quality evidence from non-tertiary or rural hospitals in low-income countries is lacking. Studies focusing on these settings should therefore be prioritized.</p><p>The effectiveness of the interventions varied across the studies, even those that implemented similar interventions. This is likely due to differences in the intervention or the implementation strategy, which may have been adapted to fit local circumstances. A detailed description of the intervention and the implementation strategy is therefore mandatory to interpret the study findings. Stewardship interventions in hospitals usually aim to change individual prescriber&#x02019;s behaviour. This behaviour is influenced by social norms, attitudes and beliefs.<xref rid="R50" ref-type="bibr"><sup>50</sup></xref> These are therefore important determinants of the effectiveness of the intervention and should be an integral part of studies of stewardship interventions. For this reason, collaboration with behavioural scientists has been recommended.<xref rid="R46" ref-type="bibr"><sup>46</sup></xref> None of the included studies reported behaviour determinants.</p><p>Our review has several limitations. We defined a broad search strategy, allowing different settings, participants, interventions and outcomes to be included. This strategy provides a good overview of what evidence is available, but limits the generalizability of the findings. Moreover, to ensure the validity of the results, studies had to fulfil high methodological standards to be included. This led to discarding numerous lower quality studies. Also, we did not include studies that only reported cost (effectiveness) as an outcome, as these require a different analysis model. Lastly, due to publication bias (not reporting negative results) and language restrictions we may have missed certain studies.</p><p>We conclude that, based on the currently available evidence, general recommendations regarding the effectiveness of antibiotic stewardship interventions in low- and middle-income countries cannot be made. As many hospitals in low- and middle-income countries are setting up antibiotic stewardship programmes, what should be the way forward? On the basis of our findings, we suggest the following actions should be prioritized to strengthen the evidence base: (i)&#x000a0;provision of methodological and statistical support for commonly used, complex study designs such as interrupted-time-series; (ii)&#x000a0;seeking consensus on relevant and feasible outcome measurements for low- and middle-income countries; (iii)&#x000a0;performing methodologically solid studies in settings such as non-tertiary, rural and public hospitals in low-income countries; and (iv)&#x000a0;accurate descriptions of interventions, implementation strategies and inclusion of behavioural aspects. While awaiting the effect of these actions, the current lack of evidence should not prevent health-care workers from engaging in stewardship. Evidence and examples both from high- and low-and middle-income countries can inspire and provide guidance in the meantime.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>&#x02013;</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref></p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Tine Verdonck, Johan van Griensven, Kristien Wouters and Jan Jacobs.</p></ack><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>Janneke Cox received unrestricted funding from the Baillet-Latour fund.</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Holmes</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Sundsfjord</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Steinbakk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Regmi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karkey</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>Understanding the mechanisms and drivers of antimicrobial resistance.</article-title>
<source>Lancet</source>. <year>2016</year>
<month>1</month>
<day>9</day>;<volume>387</volume>(<issue>10014</issue>):<fpage>176</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)00473-0</pub-id><pub-id pub-id-type="pmid">26603922</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="book">Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.</mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Leopold</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>van Leth</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tarekegn</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Schultsz</surname>
<given-names>C</given-names></string-name>. <article-title>Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review.</article-title>
<source>J Antimicrob Chemother</source>. <year>2014</year>
<month>9</month>;<volume>69</volume>(<issue>9</issue>):<fpage>2337</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dku176</pub-id><pub-id pub-id-type="pmid">24879668</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Lestari</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Severin</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Verbrugh</surname>
<given-names>HA</given-names></string-name>. <article-title>Antimicrobial resistance among pathogenic bacteria in Southeast Asia.</article-title>
<source>Southeast Asian J Trop Med Public Health</source>. <year>2012</year>
<month>3</month>;<volume>43</volume>(<issue>2</issue>):<fpage>385</fpage>&#x02013;<lpage>422</lpage>.<pub-id pub-id-type="pmid">23082591</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Laxminarayan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Duse</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wattal</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zaidi</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Wertheim</surname>
<given-names>HF</given-names></string-name>, <string-name><surname>Sumpradit</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal>
<article-title>Antibiotic resistance-the need for global solutions.</article-title>
<source>Lancet Infect Dis</source>. <year>2013</year>
<month>12</month>;<volume>13</volume>(<issue>12</issue>):<fpage>1057</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(13)70318-9</pub-id><pub-id pub-id-type="pmid">24252483</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="book"><source>The evolving threat of antimicrobial resistance: options for action.</source>
<publisher-loc>Geneva</publisher-loc>: <collab>World Health Organization</collab>; <year>2012</year>.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="book"><source>Global action plan on antimicrobial resistance.</source>
<publisher-loc>Geneva</publisher-loc>: <collab>World Health Organization</collab>; <year>2015</year>.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Davey</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Marwick</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Charani</surname>
<given-names>E</given-names></string-name>, <string-name><surname>McNeil</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>Interventions to improve antibiotic prescribing practices for hospital inpatients.</article-title>
<source>Cochrane Database Syst Rev</source>. <year>2017</year>
<month>2</month>
<day>9</day>;<volume>2</volume>:<fpage>CD003543</fpage>.<pub-id pub-id-type="pmid">28178770</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Schuts</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Hulscher</surname>
<given-names>MEJL</given-names></string-name>, <string-name><surname>Mouton</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Verduin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Stuart</surname>
<given-names>JWTC</given-names></string-name>, <string-name><surname>Overdiek</surname>
<given-names>HWPM</given-names></string-name>, <etal>et al.</etal>
<article-title>Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.</article-title>
<source>Lancet Infect Dis</source>. <year>2016</year>
<month>7</month>;<volume>16</volume>(<issue>7</issue>):<fpage>847</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(16)00065-7</pub-id><pub-id pub-id-type="pmid">26947617</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Honda</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ohmagari</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tokuda</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mattar</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Warren</surname>
<given-names>DK</given-names></string-name>. <article-title>Antimicrobial stewardship in inpatient settings in the Asia Pacific Region: a systematic review and meta-analysis.</article-title>
<source>Clin Infect Dis</source>. <year>2017</year>
<month>5</month>
<day>15</day>;<volume>64</volume>
<issue>suppl_2</issue>:<fpage>S119</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cix017</pub-id><pub-id pub-id-type="pmid">28475777</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Cox</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Vlieghe</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mendelson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wertheim</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ndegwa</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Villegas</surname>
<given-names>MV</given-names></string-name>, <etal>et al.</etal>
<article-title>Antibiotic stewardship in low- and middle-income countries: the same but different?</article-title>
<source>Clin Microbiol Infect</source>. <year>2017</year>
<month>11</month>;<volume>23</volume>(<issue>11</issue>):<fpage>812</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2017.07.010</pub-id><pub-id pub-id-type="pmid">28712667</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Howard</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pulcini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Levy Hara</surname>
<given-names>G</given-names></string-name>, <string-name><surname>West</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Gould</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Harbarth</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>; <collab>ESCMID Study Group for Antimicrobial Policies (ESGAP)</collab>; <collab>ISC Group on Antimicrobial Stewardship</collab>. <article-title>An international cross-sectional survey of antimicrobial stewardship programmes in hospitals.</article-title>
<source>J Antimicrob Chemother</source>. <year>2015</year>
<month>4</month>;<volume>70</volume>(<issue>4</issue>):<fpage>1245</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">25527272</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="book"><string-name><surname>Van Dijck</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cox</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Vlieghe</surname>
<given-names>E</given-names></string-name>. <source>The impact of antibiotic stewardship interventions in hospitalized patients in low- and middle- income countries: a systematic literature review. PROSPERO International prospective register of systematic reviews.</source> [<comment>internet</comment>]. <publisher-loc>York</publisher-loc>: <publisher-name>University of York</publisher-name>; <year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42016042019">http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42016042019</ext-link> [<comment>cited 2018 Jan 3</comment>].</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="web">World Bank country and lending groups [internet]. Washington: World Bank; 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://data.worldbank.org/about/country-and-lending-groups">http://data.worldbank.org/about/country-and-lending-groups</ext-link> [cited 2016 Jan 24].</mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="web">Suggested risk of bias criteria for EPOC reviews [internet]. London: Cochrane; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="http://epoc.cochrane.org/epoc-specific-resources-review-authors">http://epoc.cochrane.org/epoc-specific-resources-review-authors</ext-link> [cited 2017 Dec 17].</mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liberati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Altman</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Group</surname>
<given-names>P</given-names></string-name>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.</article-title>
<source>PLoS Med</source>. <year>2009</year>
<month>7</month>
<day>21</day>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Ding</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>K</given-names></string-name>. <article-title>Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis.</article-title>
<source>Int J Med Sci</source>. <year>2013</year>
<month>5</month>
<day>20</day>;<volume>10</volume>(<issue>7</issue>):<fpage>903</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.4972</pub-id><pub-id pub-id-type="pmid">23781136</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Long</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>J</given-names></string-name>. <article-title>Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.</article-title>
<source>Respirology</source>. <year>2011</year>
<month>7</month>;<volume>16</volume>(<issue>5</issue>):<fpage>819</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1843.2011.01978.x</pub-id><pub-id pub-id-type="pmid">21507143</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Long</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>GZ</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>XM</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>JG</given-names></string-name>, <etal>et al.</etal>
<article-title>Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up.</article-title>
<source>Crit Care</source>. <year>2014</year>
<month>9</month>
<day>5</day>;<volume>18</volume>(<issue>5</issue>):<fpage>471</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-014-0471-7</pub-id><pub-id pub-id-type="pmid">25189222</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Maravi&#x00107;-Stojkovi&#x00107;</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lausevi&#x00107;-Vuk</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jovi&#x00107;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rankovi&#x00107;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Borzanovi&#x00107;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Marinkovi&#x00107;</surname>
<given-names>J</given-names></string-name>. <article-title>Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.</article-title>
<source>Srp Arh Celok Lek</source>. <year>2011</year>
<season>Nov-Dec</season>;<volume>139</volume>(<issue>11-12</issue>):<fpage>736</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2298/SARH1112736M</pub-id><pub-id pub-id-type="pmid">22338468</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Tang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.</article-title>
<source>BMC Infect Dis</source>. <year>2013</year>
<month>12</month>
<day>17</day>;<volume>13</volume>(<issue>1</issue>):<fpage>596</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-13-596</pub-id><pub-id pub-id-type="pmid">24341820</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Najafi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khodadadian</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sanatkar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shariat Moharari</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Etezadi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ahmadi</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal>
<article-title>The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit.</article-title>
<source>Acta Med Iran</source>. <year>2015</year>;<volume>53</volume>(<issue>9</issue>):<fpage>562</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">26553084</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Oliveira</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Botoni</surname>
<given-names>FA</given-names></string-name>, <string-name><surname>Oliveira</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Silva</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Pereira</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Serufo</surname>
<given-names>JC</given-names></string-name>, <etal>et al.</etal>
<article-title>Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.</article-title>
<source>Crit Care Med</source>. <year>2013</year>
<month>10</month>;<volume>41</volume>(<issue>10</issue>):<fpage>2336</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0b013e31828e969f</pub-id><pub-id pub-id-type="pmid">23921272</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Qu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ji</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ling</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ye</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>YY</given-names></string-name>, <etal>et al.</etal>
<article-title>Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial.</article-title>
<source>Saudi Med J</source>. <year>2012</year>
<month>4</month>;<volume>33</volume>(<issue>4</issue>):<fpage>382</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22485232</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Bucher</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rivara</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Brice&#x000f1;o</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Huicho</surname>
<given-names>L</given-names></string-name>. <article-title>[Use of a rapid rotavirus test in prescription of antibiotics in acute diarrhea in pediatrics: an observational, randomized, controlled study]</article-title>. <source>Rev Gastroenterol Peru</source>. <year>2012</year>
<season>Jan-Mar</season>;<volume>32</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>5</lpage>. Spanish.<pub-id pub-id-type="pmid">22476173</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>&#x000d6;zkaya </surname><given-names>E</given-names></string-name>, <string-name><surname>Cambaz</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Co&#x0015f;kun</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mete</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Geyik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Samanci</surname>
<given-names>N</given-names></string-name>. <article-title>The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department.</article-title>
<source>Acta Paediatr</source>. <year>2009</year>
<month>10</month>;<volume>98</volume>(<issue>10</issue>):<fpage>1589</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2009.01384.x</pub-id><pub-id pub-id-type="pmid">19555447</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>G&#x000fc;lmezoglu</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Langer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Piaggio</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lumbiganon</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Villar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Grimshaw</surname>
<given-names>J</given-names></string-name>. <article-title>Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices.</article-title>
<source>BJOG</source>. <year>2007</year>
<month>1</month>;<volume>114</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-0528.2006.01091.x</pub-id><pub-id pub-id-type="pmid">17010115</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Tuon</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Gasparetto</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wollmann</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Moraes</surname>
<given-names>TPD</given-names></string-name>. <article-title>Mobile health application to assist doctors in antibiotic prescription &#x02013; an approach for antibiotic stewardship.</article-title>
<source>Braz J Infect Dis</source>. <year>2017</year>
<season>Nov-Dec</season>;<volume>21</volume>(<issue>6</issue>):<fpage>660</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjid.2017.08.002</pub-id><pub-id pub-id-type="pmid">28941393</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Brink</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Messina</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Feldman</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Becker</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Goff</surname>
<given-names>DA</given-names></string-name>, <etal>et al.</etal>; <collab>Netcare Antimicrobial Stewardship Study Alliance</collab>. <article-title>Antimicrobial stewardship across 47 South African hospitals: an implementation study.</article-title>
<source>Lancet Infect Dis</source>. <year>2016</year>
<month>9</month>;<volume>16</volume>(<issue>9</issue>):<fpage>1017</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(16)30012-3</pub-id><pub-id pub-id-type="pmid">27312577</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Pharmacist-driven antimicrobial stewardship in intensive care units in East China: a multicenter prospective cohort study.</article-title>
<source>Am J Infect Control</source>. <year>2017</year>
<month>9</month>
<day>1</day>;<volume>45</volume>(<issue>9</issue>):<fpage>983</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajic.2017.02.021</pub-id><pub-id pub-id-type="pmid">28596021</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Wattal</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Khanna</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Goel</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Oberoi</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Rao</surname>
<given-names>BK</given-names></string-name>. <article-title>Antimicrobial prescribing patterns of surgical speciality in a tertiary care hospital in India: role of persuasive intervention for changing antibiotic prescription behaviour.</article-title>
<source>Indian J Med Microbiol</source>. <year>2017</year>
<season>Jul-Sep</season>;<volume>35</volume>(<issue>3</issue>):<fpage>369</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">29063881</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Rattanaumpawan</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sutha</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Thamlikitkul</surname>
<given-names>V</given-names></string-name>. <article-title>Effectiveness of drug use evaluation and antibiotic authorization on patients&#x02019; clinical outcomes, antibiotic consumption, and antibiotic expenditures.</article-title>
<source>Am J Infect Control</source>. <year>2010</year>
<month>2</month>;<volume>38</volume>(<issue>1</issue>):<fpage>38</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajic.2009.04.288</pub-id><pub-id pub-id-type="pmid">19699014</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Qi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital.</article-title>
<source>Int J Clin Pharm</source>. <year>2011</year>
<month>12</month>;<volume>33</volume>(<issue>6</issue>):<fpage>929</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1007/s11096-011-9577-z</pub-id><pub-id pub-id-type="pmid">22068326</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Hadi</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Keuter</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van Asten</surname>
<given-names>H</given-names></string-name>, <string-name><surname>van den Broek</surname>
<given-names>P</given-names></string-name>; <collab>Study Group &#x02018;Antimicrobial resistance in Indonesia: Prevalence and Prevention&#x02019; (AMRIN)</collab>. <article-title>Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital.</article-title>
<source>Trop Med Int Health</source>. <year>2008</year>
<month>7</month>;<volume>13</volume>(<issue>7</issue>):<fpage>888</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3156.2008.02080.x</pub-id><pub-id pub-id-type="pmid">18373509</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Chandy</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Naik</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Charles</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jeyaseelan</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Naumova</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>The impact of policy guidelines on hospital antibiotic use over a decade: a segmented time series analysis.</article-title>
<source>PLoS One</source>. <year>2014</year>
<month>3</month>
<day>19</day>;<volume>9</volume>(<issue>3</issue>):<fpage>e92206</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0092206</pub-id><pub-id pub-id-type="pmid">24647339</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Aiken</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Wanyoro</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Mwangi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Juma</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mugoya</surname>
<given-names>IK</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>JA</given-names></string-name>. <article-title>Changing use of surgical antibiotic prophylaxis in Thika Hospital, Kenya: a quality improvement intervention with an interrupted time series design.</article-title>
<source>PLoS One</source>. <year>2013</year>
<month>11</month>
<day>11</day>;<volume>8</volume>(<issue>11</issue>):<fpage>e78942</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0078942</pub-id><pub-id pub-id-type="pmid">24244390</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Opondo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ayieko</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ntoburi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wagai</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Opiyo</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Irimu</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Effect of a multi-faceted quality improvement intervention on inappropriate antibiotic use in children with non-bloody diarrhoea admitted to district hospitals in Kenya.</article-title>
<source>BMC Pediatr</source>. <year>2011</year>
<month>11</month>
<day>25</day>;<volume>11</volume>(<issue>1</issue>):<fpage>109</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2431-11-109</pub-id><pub-id pub-id-type="pmid">22117602</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Gong</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>X</given-names></string-name>, <string-name><surname>He</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Effect of financially punished audit and feedback in a pediatric setting in China, within an antimicrobial stewardship program, and as part of an international accreditation process.</article-title>
<source>Front Public Health</source>. <year>2016</year>
<month>5</month>
<day>18</day>;<volume>4</volume>:<fpage>99</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2016.00099</pub-id><pub-id pub-id-type="pmid">27242991</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Weinberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fuentes</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Ruiz</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>Lozano</surname>
<given-names>FW</given-names></string-name>, <string-name><surname>Angel</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gaitan</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal>
<article-title>Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods.</article-title>
<source>Arch Intern Med</source>. <year>2001</year>
<month>10</month>
<day>22</day>;<volume>161</volume>(<issue>19</issue>):<fpage>2357</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1001/archinte.161.19.2357</pub-id><pub-id pub-id-type="pmid">11606152</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>P&#x000e9;rez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dennis</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Castro</surname>
<given-names>AY</given-names></string-name>, <string-name><surname>Delgado</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lozano</surname>
<given-names>JM</given-names></string-name>, <etal>et al.</etal>
<article-title>An interrupted time series analysis of parenteral antibiotic use in Colombia.</article-title>
<source>J Clin Epidemiol</source>. <year>2003</year>
<month>10</month>;<volume>56</volume>(<issue>10</issue>):<fpage>1013</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/S0895-4356(03)00163-X</pub-id><pub-id pub-id-type="pmid">14568634</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Magedanz</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Silliprandi</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>dos Santos</surname>
<given-names>RP</given-names></string-name>. <article-title>Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study.</article-title>
<source>Int J Clin Pharm</source>. <year>2012</year>
<month>4</month>;<volume>34</volume>(<issue>2</issue>):<fpage>290</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1007/s11096-012-9621-7</pub-id><pub-id pub-id-type="pmid">22382886</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Bao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Meng</surname>
<given-names>W</given-names></string-name>, <etal>et al.</etal>
<article-title>Significant reduction of antibiotic consumption and patients&#x02019; costs after an action plan in China, 2010&#x02013;2014.</article-title>
<source>PLoS One</source>. <year>2015</year>
<month>3</month>
<day>13</day>;<volume>10</volume>(<issue>3</issue>):<fpage>e0118868</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0118868</pub-id><pub-id pub-id-type="pmid">25767891</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>He</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Skoog</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Changes in patterns of antibiotic use in Chinese public hospitals (2005&#x02013;2012) and a benchmark comparison with Sweden in 2012.</article-title>
<source>J Glob Antimicrob Resist</source>. <year>2015</year>
<month>6</month>;<volume>3</volume>(<issue>2</issue>):<fpage>95</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgar.2015.03.001</pub-id><pub-id pub-id-type="pmid">27873677</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="web">The WHO Reproductive Health Library [internet]. Geneva: World Health Organization; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://extranet.who.int/rhl">https://extranet.who.int/rhl</ext-link> [cited 2017 Dec 17].</mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>de Kraker</surname>
<given-names>MEA</given-names></string-name>, <string-name><surname>Abbas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Huttner</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Harbarth</surname>
<given-names>S</given-names></string-name>. <article-title>Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions.</article-title>
<source>Clin Microbiol Infect</source>. <year>2017</year>
<month>11</month>;<volume>23</volume>(<issue>11</issue>):<fpage>819</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2017.05.019</pub-id><pub-id pub-id-type="pmid">28571767</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Hulscher</surname>
<given-names>MEJL</given-names></string-name>, <string-name><surname>Prins</surname>
<given-names>JM</given-names></string-name>. <article-title>Antibiotic stewardship: does it work in hospital practice? A review of the evidence base.</article-title>
<source>Clin Microbiol Infect</source>. <year>2017</year>
<month>11</month>;<volume>23</volume>(<issue>11</issue>):<fpage>799</fpage>&#x02013;<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2017.07.017</pub-id><pub-id pub-id-type="pmid">28750920</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Barlam</surname>
<given-names>TF</given-names></string-name>, <string-name><surname>Cosgrove</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Abbo</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>MacDougall</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Schuetz</surname>
<given-names>AN</given-names></string-name>, <string-name><surname>Septimus</surname>
<given-names>EJ</given-names></string-name>, <etal>et al.</etal>
<article-title>Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.</article-title>
<source>Clin Infect Dis</source>. <year>2016</year>
<month>5</month>
<day>15</day>;<volume>62</volume>(<issue>10</issue>):<fpage>e51</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciw118</pub-id><pub-id pub-id-type="pmid">27080992</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Morris</surname>
<given-names>AM</given-names></string-name>. <article-title>Antimicrobial stewardship programs: appropriate measures and metrics to study their impact.</article-title>
<source>Curr Treat Options Infect Dis</source>. <year>2014</year>;<volume>6</volume>(<issue>2</issue>):<fpage>101</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s40506-014-0015-3</pub-id><pub-id pub-id-type="pmid">25999798</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Moehring</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Cochran</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Hicks</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Srinivasan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dodds Ashley</surname>
<given-names>ES</given-names></string-name>; <collab>Structured Taskforce of Experts Working at Reliable Standards for Stewardship (STEWARDS) Panel</collab>. <article-title>Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings.</article-title>
<source>Clin Infect Dis</source>. <year>2017</year>
<month>2</month>
<day>1</day>;<volume>64</volume>(<issue>3</issue>):<fpage>377</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciw787</pub-id><pub-id pub-id-type="pmid">27927866</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Charani</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sevdalis</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Alexandrou</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sibley</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mullett</surname>
<given-names>D</given-names></string-name>, <etal>et al.</etal>
<article-title>Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review.</article-title>
<source>Clin Infect Dis</source>. <year>2011</year>
<month>10</month>;<volume>53</volume>(<issue>7</issue>):<fpage>651</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cir445</pub-id><pub-id pub-id-type="pmid">21890770</pub-id></mixed-citation></ref></ref-list></back></article>